{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191976"], "tissue": "Primary tumor", "histology_cpr": "EndoG3", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "disease": "EndoG3", "sample_type": "Serous carcinoma", "isolate": "C3"}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biosample_accession": "GSM8191976", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "EndoG3", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C3", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509182"], "tissue": "Omentum", "roi": "004", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509182", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Omentum", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509182", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "004", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509533"], "tissue": "Fallopian Tube", "roi": "012", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509533", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Fallopian Tube", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Full ROI", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509533", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Mesenchymal Stem Cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity. The study reveals transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185483"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185483", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185483", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509300"], "tissue": "Omentum", "roi": "004", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509300", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Omentum", "sample_type": "Tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509300", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "004", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191727"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Serous carcinoma", "disease": "HGSC", "cell_type": "C2", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "age": "Not provided", "isolate": "GSM8191727"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191727", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "serous carcinoma cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191805"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191805", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "cell_type": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191805", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191836"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191836", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian tissue", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer cells", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Diseased", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191836", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185428"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_name": "GSM8185428", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSM8185428", "sample_name": "NA", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192002"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "disease": "HGSC", "disease_stage": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192002", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185448"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C4"}, "LLM": {"sample_name": "", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8185448", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "C4", "race": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "isolate": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185560"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "cell_type": "Cancer cell", "sample_type": "tissue sample", "disease_stage": "Not provided", "health_state": "Diseased"}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8185560", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "ovary", "disease": "ovarian neoplasm", "sample_type": "primary tumor", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "population": "C3", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191856"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_name": "GSM8191856", "tissue": "HGSC", "disease": "Serous carcinoma", "population": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191856", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191715"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8191715", "tissue": "HGSC", "disease": "Serous carcinoma", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191715", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191923"], "histology_cpr": "HGSC", "histology_iti": "Other", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "GSM8191923", "age": "NA", "biomaterial_provider": "NA", "collection_date": "NA", "geo_loc_name": "NA", "sex": "NA", "tissue": "HGSC", "cell_line": "NA", "cell_subtype": "Other", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian Cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191923", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "NA", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304120"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR4", "cell type": "epithelial cells", "treatment": "DMSO (control)"}, "LLM": {"sample_name": "GSM8304120", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "isolate": "OVCAR4", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR4", "cell_subtype": null, "cell_type": "epithelial cells", "culture_collection": null, "dev_stage": null, "disease": "ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "cell culture", "treatment": "DMSO (control)", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "GSE268985", "sample_name": "GSM8304120", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "OVCAR4", "cell_subtype": "NA", "cell_type": "epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "DMSO (control)", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191946"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191946", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "cell_type": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "HGSC", "sample_type": "tumor tissue", "biomaterial_provider": "Not Provided", "isolate": "Not Provided", "age": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "treatment": "Not Provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191946", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185590"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_type": "primary tumor", "organism": "Homo sapiens", "cell_type": "Serous carcinoma", "phenotype": "HGSC", "sample_name": "GSM8185590"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185590", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191830"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Human", "disease": "Serous carcinoma", "treatment": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8191830", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "cell_type": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "sex": "NA", "age": "NA", "tissue": "ovary", "organism": "Homo sapiens", "isolate": "NA", "biosample_accession": "HGSC", "bioproject_accession": "GSE263455"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185618"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "primary tumor", "disease": "ovarian cancer", "sample_type": "primary tumor", "cell_type": "Serous carcinoma", "phenotype": "HGSC"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185618", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian neoplasm", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191977"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191977", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191977", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509386"], "tissue": "Omentum", "roi": "002", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509386", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not collected", "biomaterial_provider": "not provided", "collection_date": "not collected", "geo_loc_name": "not collected", "sex": "not determined", "tissue": "Omentum", "cell_line": "not applicable", "cell_subtype": "not collected", "cell_type": "not collected", "culture_collection": "not applicable", "dev_stage": "not collected", "disease": "serous ovarian cancer", "disease_stage": "high grade", "ethnicity": "not collected", "health_state": "disease", "karyotype": "not collected", "phenotype": "not collected", "population": "not collected", "race": "not collected", "sample_type": "tissue sample", "treatment": "not collected", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509386", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "002", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509440"], "tissue": "Fallopian Tube", "roi": "014", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509440", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Fallopian Tube", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509440", "sample_name": "014", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509363"], "tissue": "Ovary", "roi": "009", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509363", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509363", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "009", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509211"], "tissue": "Ovary", "roi": "006", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509211", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "006", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Ovary", "cell_line": null, "cell_subtype": null, "cell_type": "Stroma", "culture_collection": null, "dev_stage": null, "disease": "high grade serous ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "Tissue sample", "treatment": null, "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509211", "sample_name": "006", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous ovarian cancer", "disease_stage": "high grade", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191752"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191752", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not Provided", "isolate": "Not Provided", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Ovarian", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Cancer", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Tissue Sample", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191752", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "ovary", "cell_type": "Serous carcinoma", "biomaterial_provider": "NA", "sex": "NA", "age": "NA", "organism": "NA", "isolate": "NA", "bioproject_accession": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304117"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR3", "cell type": "epithelial cells", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours"}, "LLM": {"sample_name": "GSM8304117", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "isolate": "OVCAR3", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not applicable", "tissue": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR3", "cell_subtype": "not provided", "cell_type": "epithelial cells", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "cancer", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "cell culture", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "GSE268985", "sample_name": ["GSM8304117"], "sample_title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "OVCAR3", "cell_subtype": "NA", "cell_type": "epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185458"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_type": "tissue sample", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "isolate": "GSM8185458", "cell_type": "Serous carcinoma", "phenotype": "HGSC", "population": "C2"}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8185458", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192078"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192078", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "Serous carcinoma", "disease_stage": "HGSC", "sample_type": "tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192078", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian neoplasm", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191704"], "histology_cpr": "EndoG3", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191704", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Endometrioid carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "EndoG3", "cell_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191704", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "Endometrioid carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "EndoG3", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185572"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185572", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_type": "Serous carcinoma", "disease_stage": "HGSC", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185572", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185604"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "age": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "HGSC", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191738"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Serous carcinoma", "disease": "HGSC", "sample_type": "C2"}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8191738", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "ovary", "cell_type": "NA", "sample_type": "tumor", "age": "NA", "sex": "NA", "race": "NA", "ethnicity": "NA", "health_state": "NA", "biomaterial_provider": "NA", "disease_stage": "NA", "phenotype": "NA", "population": "NA", "cell_subtype": "Serous carcinoma", "cell_line": "NA", "culture_collection": "NA", "dev_stage": "NA", "karyotype": "NA", "isolate": "NA", "organism": "Homo sapiens", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191814"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "HGSC", "disease": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191814", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191670"], "histology_cpr": "EndoG3", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191670", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not Provided", "isolate": "Not Provided", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Endometrioid carcinoma", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "Endometrioid carcinoma", "disease_stage": "EndoG3", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Not Provided", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "Endometrioid carcinoma", "sample_type": "C3", "tissue": "EndoG3", "biomaterial_provider": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "biosample_accession": "GSM8191670", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191819"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "JGOG3025-TR2", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "Ovarian", "sample_type": "Tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below.", "isolate": "HGSC", "cell_type": "Cancer cell", "cell_subtype": "HGSC", "cell_line": "C2", "health_state": "Diseased", "phenotype": "Cancerous", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease_stage": "Not provided", "ethnicity": "Not provided", "karyotype": "Not provided", "population": "Not provided", "race": "Not provided", "treatment": "Not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191819", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021621"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021621", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "tissue": "Omentum", "cell_type": "HGSOC", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": "GSM7021621", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "NA", "organism": "Homo Sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "High-grade serous ovarian cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor-infiltrating immune cells", "treatment": "Neo-adjuvant chemotherapy", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185470"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Endometrioid carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "Not Provided", "isolate": "Not Provided", "age": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "tumor tissue", "treatment": "Not Provided"}, "LLM+CEDAR": {"sample_name": "GSM8185470", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Endometrioid carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "C3", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185609"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample", "cell_type": "cancer cell", "health_state": "diseased", "disease_stage": "not provided", "phenotype": "HGSC", "isolate": "GSM8185609"}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8185609", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185393"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "disease_stage": "HGSC", "phenotype": "Serous carcinoma", "population": "C1"}, "LLM+CEDAR": {"sample_name": "GSM8185393", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "ovarian", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "age": "NA", "organism": "NA", "isolate": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "primary tumor", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "biosample_accession": "NA", "bioproject_accession": "GSE263455"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191749"], "histology_cpr": "HGSC", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C2"}, "LLM": {"title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Endometrioid carcinoma", "disease": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Cancer tissue sample", "disease_stage": "C2", "collection_date": "not provided", "geo_loc_name": "not provided", "age": "not provided", "sex": "not provided", "biomaterial_provider": "not provided", "isolate": "not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191749", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Endometrioid carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509261"], "tissue": "Lymph Node", "roi": "003", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509261", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "biomaterial_provider": "Unknown", "tissue": "Lymph Node", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "Stroma"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509261"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Lymph Node", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "1", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191728"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Serous carcinoma", "sample_type": "HGSC", "cell_line": "C1"}, "LLM+CEDAR": {"sample_name": "GSM8191728", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "ovary", "disease_stage": "High-grade serous carcinoma", "cell_type": "Serous carcinoma", "biomaterial_provider": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C1", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192103"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192103", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "HGSC", "sample_type": "tissue sample", "disease_stage": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192103", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-Grade Serous Cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192230"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "disease": "Serous carcinoma", "sample_type": "HGSC"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192230", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509309"], "tissue": "Omentum", "roi": "009", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509309", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Omentum", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509309", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "NA", "organism": "NA", "isolate": "009", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191997"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "Assigned Cluster: C3", "bioproject_accession": "GSE263455", "organism": "Not Provided", "isolate": "GSM8191997", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Primary tumor", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "HGSC", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Serous carcinoma", "treatment": "Not Provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191997", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "C3", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509374"], "tissue": "Fallopian Tube", "roi": "005", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509374", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Fallopian Tube", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509374", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "005", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191719"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Ovarian", "disease": "Serous carcinoma", "description": "This sample data is related to an ovarian cancer cohort study. The histology of the sample is categorized as HGSC (High-grade serous carcinoma) and is assigned to cluster C2."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8191719", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509474"], "tissue": "Omentum", "roi": "001", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509474", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509474", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192042"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Not provided", "tissue": "Primary tumor", "disease": "HGSC", "phenotype": "Serous carcinoma", "sample_name": "GSM8192042", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "C2", "treatment": "Not provided", "age": "Not provided", "isolate": "Not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192042", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "tumor cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509418"], "tissue": "Omentum", "roi": "011", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509418", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Omentum", "cell_line": null, "cell_subtype": null, "cell_type": "CD20", "culture_collection": null, "dev_stage": null, "disease": "high grade serous ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": null, "treatment": null, "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509418", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "011", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192183"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192183", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not Provided", "isolate": "Not Provided", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Primary tumor", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "Serous carcinoma", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "HGSC", "population": "Not Provided", "race": "Not Provided", "sample_type": "Primary tumor", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192183", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "ovarian cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185395"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "bioproject_accession": "GSM8185395", "organism": null, "isolate": null, "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "primary tumor", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "primary tumor", "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below.", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185395", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian neoplasm", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192116"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192116", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "Homo sapiens", "tissue": "Primary tumor", "bioproject_accession": "GSE263455", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "Serous carcinoma", "disease_stage": "HGSC", "sample_type": "tissue sample", "geo_loc_name": "not provided", "sex": "not provided", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "isolate": "not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192116", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191713"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191713", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Serous carcinoma", "cell_type": "Cancer Cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High-grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8191713", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185580"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSM8185580", "sample_name": "NA", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191763"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "HGSC", "tissue": "Serous carcinoma", "cell_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191763", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191771"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_name": "GSE263455", "bioproject_accession": "GSM8191771", "organism": "Human", "tissue": "Serous carcinoma", "disease": "HGSC", "phenotype": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191771", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Carcinoma cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509366"], "tissue": "Ovary", "roi": "010", "type": "Stroma", "batch": "2"}, "LLM": {"sample_name": "GSM8509366", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Ovary", "cell_line": "Not applicable", "cell_subtype": "Not applicable", "cell_type": "Stroma", "culture_collection": "Not applicable", "dev_stage": "Not applicable", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509366", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192177"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192177", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Not provided", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192177", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "Ovarian serous cystadenocarcinoma", "tissue": "ovarian tissue", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "organism": "NA", "isolate": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185498"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185498", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_type": "Serous carcinoma", "phenotype": "HGSC", "health_state": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185498", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192004"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192004", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC, Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below.", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192004", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "C2", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304106"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR3", "cell type": "epithelial cells", "treatment": "DMSO (control)"}, "LLM": {"sample_name": "GSM8304106", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "cell_line": "OVCAR3", "cell_type": "epithelial cells", "tissue": "high-grade serous ovarian adenocarcinoma", "treatment": "DMSO (control)", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "GSE268985", "sample_name": "GSM8304106", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "OVCAR3", "cell_subtype": "NA", "cell_type": "epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "cell line", "treatment": "DMSO (control)", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509511"], "tissue": "Ovary", "roi": "016", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509511", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "female", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509511"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191893"], "histology_cpr": "EndoG3", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8191893", "tissue": "EndoG3", "disease": "Endometrioid carcinoma", "population": "C4"}, "LLM+CEDAR": {"sample_name": "GSM8191893", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "endometrium", "cell_line": "NA", "cell_subtype": "EndoG3", "cell_type": "endometrial carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "endometrial carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192057"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8192057", "tissue": "Primary tumor", "disease": "HGSC", "sample_type": "Serous carcinoma", "treatment": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192057", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509265"], "tissue": "Lymph Node", "roi": "005", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509265", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Human", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Lymph Node", "cell_line": "Not provided", "cell_subtype": "CD20", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509265", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "005", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Lymph Node", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancers", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "1", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509519"], "tissue": "Fallopian Tube", "roi": "001", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509519", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "collection_date": "NA", "geo_loc_name": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue sample", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509519", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "2", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185531"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "-"}, "LLM": {"sample_name": "GSM8185531", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185531", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192192"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192192", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tumor tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192192", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509296"], "tissue": "Omentum", "roi": "002", "type": "Tumor", "batch": "1"}, "LLM": {"sample_name": "GSM8509296", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Omentum", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "Tumor", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "Tumor", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509296", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "002", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "Tumor", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191862"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "HGSC", "tissue": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191862", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185626"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "EndoG3", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185626", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "primary tumor", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185626", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "primary tumor", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian neoplasm", "disease_stage": "EndoG3", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509495"], "tissue": "Omentum", "roi": "014", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509495", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "biomaterial_provider": "Not provided", "tissue": "Omentum", "cell_type": "CD20", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509495", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "014", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192189"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below. Histology CPR: HGSC, Histology ITI: Serous carcinoma, Assigned Cluster: C3"}, "LLM+CEDAR": {"sample_name": "GSM8192189", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "tissue": "ovarian tissue", "disease": "high-grade serous ovarian carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Primary tumor", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191784"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191784", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Ovarian", "disease": "Serous carcinoma", "cell_type": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "cell_line": "", "cell_subtype": "", "culture_collection": "", "dev_stage": "", "disease_stage": "C3", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": ""}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191784", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "serous carcinoma cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509499"], "tissue": "Ovary", "roi": "004", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509499", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509499", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Ovary", "disease": "high grade serous ovarian cancer", "sample_type": "Immune", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192135"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192135", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192135", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185605"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185605", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below. Histology cpr is HGSC, histology iti is Serous carcinoma and assigned cluster is C3."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185605", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "HGSC, Serous carcinoma, assigned cluster: C3"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192204"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "JGOG3025-TR2", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Serous carcinoma", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192204", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian Cancer", "disease_stage": "C3", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191722"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191722", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Cancer tissue"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191722", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192000"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192000", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "C2", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192000", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "ovary", "disease": "ovarian serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "organism": "NA", "isolate": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185429"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "organism": "", "tissue": "primary tumor", "disease": "ovarian cancer", "bioproject_accession": "GSE263455", "sample_name": "GSM8185429", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "population": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8185429", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "age": "NA", "sex": "NA", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "biosample_accession": "NA", "bioproject_accession": "NA", "isolate": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192017"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "", "tissue": "Primary tumor", "sample_name": "GSM8192017", "cell_type": "Serous carcinoma", "disease": "HGSC", "sample_type": "Primary tumor", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192017", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191896"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8191896", "bioproject_accession": "GSE263455", "tissue": "Serous carcinoma", "disease": "HGSC", "sample_type": "ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "cluster_assigned": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191896", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "C2", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509555"], "tissue": "Ovary", "roi": "014", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509555", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "sample_type": "Tissue Sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509555", "sample_name": "014", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509218"], "tissue": "Ovary", "roi": "009", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509218", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "CD20", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancers", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509218", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "009", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CD20", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185473"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185473", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185473", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185427"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "cell_type": "Serous carcinoma", "biomaterial_provider": "HGSC", "sample_type": "primary tumor", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185427", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185548"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "sample_name": "GSM8185548", "sample_type": "primary tumor", "description": "Assigned cluster C2"}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8185548", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509562"], "tissue": "Ovary", "roi": "020", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509562", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "female", "tissue": "Ovary", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "not provided", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509562", "sample_name": "020", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509471"], "tissue": "Fallopian Tube", "roi": "015", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509471", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Fallopian Tube", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509471", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192020"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "Serous carcinoma", "phenotype": "HGSC", "sample_type": "tumor", "sample_name": "GSM8192020"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192020", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251954"], "tissue": "Omentum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251954", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "high-grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor or ascites samples", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8251954", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor or ascites", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191901"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8191901", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "HGSC", "cell_line": "", "cell_subtype": "", "cell_type": "Serous carcinoma", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191901", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185457"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This sample is a part of the JGOG3025-TR2 ovarian cancer cohort study. The histology cpr is HGSC, and histology iti is Serous carcinoma. The sample is assigned to the C2 cluster."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185457", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185496"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "primary tumor", "disease": "ovarian cancer", "cell_type": "Serous carcinoma", "description": "HGSC", "sample_name": "GSM8185496"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185496", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "primary tumor", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192203"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "GSM8192203", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192203", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185403"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "EndoG3", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185403", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below. Histology CPR: EndoG3, Histology ITI: Serous carcinoma, Assigned cluster: C2"}, "LLM+CEDAR": {"sample_name": "GSM8185403", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "EndoG3", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C2", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509525"], "tissue": "Fallopian Tube", "roi": "005", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509525", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Fallopian Tube", "sample_type": "Tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509525", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "005", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "fallopian tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "immune cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191821"], "histology_cpr": "HGSC", "histology_iti": "Other", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191821", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "HGSC", "cell_line": "", "cell_subtype": "Other", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "C2", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSM8191821", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "NA", "sample_name": "JGOG3025-TR2", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "HGSC", "cell_subtype": "Other", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191773"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Ovarian cancer", "disease_stage": "HGSC", "tissue": "Serous carcinoma", "sample_type": "Tumor tissue", "cell_type": "Cancer cell", "phenotype": "C2"}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8191773", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "ovary", "cell_type": "NA", "cell_subtype": "Serous carcinoma", "age": "NA", "sex": "NA", "ethnicity": "NA", "race": "NA", "sample_type": "tumor", "phenotype": "HGSC", "health_state": "NA", "population": "NA", "disease_stage": "NA", "biomaterial_provider": "NA", "culture_collection": "NA", "karyotype": "NA", "treatment": "NA", "organism": "Homo sapiens", "isolate": "NA", "dev_stage": "NA", "cell_line": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509504"], "tissue": "Ovary", "roi": "009", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509504", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "sample_type": "Tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509504", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "009", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185468"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_name": "GSM8185468", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8185468", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "HGSC", "treatment": "NA", "disease_stage": "NA", "age": "NA", "biomaterial_provider": "NA", "culture_collection": "NA", "dev_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "bioproject_accession": "GSE263455", "biosample_accession": "NA", "isolate": "Serous carcinoma"}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021618"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021618", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "tissue": "Omentum", "cell_type": "HGSOC", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": "GSM7021618", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "NA", "organism": "Human", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSOC", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor-infiltrating immune cells", "treatment": "neo-adjuvant chemotherapy", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype. ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509584"], "tissue": "Ovary", "roi": "006", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509584", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "biomaterial_provider": "N/A", "tissue": "Ovary", "cell_type": "Immune", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSM8509584", "sample_name": "006", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191990"], "tissue": "Primary tumor", "histology_cpr": "EndoG3", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "", "isolate": "GSM8191990", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Endometrioid carcinoma", "disease_stage": "EndoG3", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "sample_name": "C4"}, "LLM+CEDAR": {"sample_name": "GSM8191990", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "tissue": "primary tumor", "disease": "Endometrioid carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "EndoG3", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509503"], "tissue": "Ovary", "roi": "008", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509503", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Diseased", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509503", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "008", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "lymphoid structure cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192108"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192108", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not Provided", "isolate": "Not Provided", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Primary tumor", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "HGSC", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Serous carcinoma", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C2", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021608"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021608", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Human", "cell_type": "HGSOC", "tissue": "Omentum", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": ["GSM7021608"], "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "NA", "organism": "Human", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSOC", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor-infiltrating immune cells", "treatment": "neo-adjuvant chemotherapy (NACT)", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191985"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "organism": "Human", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "geo_loc_name": "not provided", "isolate": "GSM8191985", "biomaterial_provider": "not provided", "collection_date": "not provided", "age": "not provided", "sex": "not provided", "cell_type": "not provided", "cell_line": "not provided", "cell_subtype": "not provided", "culture_collection": "not provided", "dev_stage": "not provided", "disease_stage": "HGSC", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "C2", "population": "not provided", "race": "not provided", "sample_type": "not provided", "treatment": "not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191985", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185538"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below. Histology CPR: HGSC. Histology ITI: Serous carcinoma. Assigned cluster: C3", "sample_type": "tissue sample"}, "LLM+CEDAR": {"sample_name": "GSM8185538", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C3", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192036"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Other", "assigned_cluster": "-"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "sample_name": "GSM8192036", "disease": "HGSC", "disease_stage": "Other"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192036", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509268"], "tissue": "Omentum", "roi": "001", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509268", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509268", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CD20", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "1", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192168"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192168", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509288"], "tissue": "Omentum", "roi": "006", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509288", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "Stroma", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tumor", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509288", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Omentum", "disease": "High grade serous ovarian cancer", "sample_type": "Stroma", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509260"], "tissue": "Lymph Node", "roi": "003", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509260", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not applicable", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not applicable", "tissue": "Lymph Node", "cell_line": "Not applicable", "cell_subtype": "Not applicable", "cell_type": "Immune", "culture_collection": "Not applicable", "dev_stage": "Not applicable", "disease": "High grade serous ovarian cancers (HGSOC)", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509260", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Lymph Node", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191808"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "gse": "GSE263455", "gsm": "GSM8191808", "tissue": "HGSC", "disease": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191808", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509407"], "tissue": "Omentum", "roi": "004", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509407", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "High grade", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509407", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "004", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185389"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8185389", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185389", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192071"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192071", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Serous carcinoma", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192071", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian neoplasm", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192085"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_name": "GSM8192085", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192085", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185513"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455_GSM8185513", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185513", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191910"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191910", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "HGSC", "sample_type": "cell culture"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191910", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509337"], "tissue": "Ovary", "roi": "010", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509337", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "female", "tissue": "Ovary", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "Stroma", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509337", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192182"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192182", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "assigned_cluster": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192182", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192079"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192079", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Serous carcinoma", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192079", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "C3", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Serous carcinoma", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191718"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "cell_line": "GSM8191718", "tissue": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "HGSC", "sample_type": "C4"}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8191718", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "High grade serous ovarian cancer", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C4", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185527"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8185527", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8185527", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Serous carcinoma", "biomaterial_provider": "NA", "sex": "NA", "age": "NA", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "isolate": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185424"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_type": "HGSC", "treatment": "Serous carcinoma", "population": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185424", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185425"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma"}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8185425", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509244"], "tissue": "Ovary", "roi": "006", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509244", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "Tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509244", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "ovary", "disease": "high grade serous ovarian cancer", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185445"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185445", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185445", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185526"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C4"}, "LLM": {"sample_name": "GSM8185526", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not Provided", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "primary tumor", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "ovarian cancer", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "tumor tissue", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185526", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185430"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C4"}, "LLM": {"sample_name": "GSM8185430", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185430", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "C4", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191666"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191666", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "HGSC", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "phenotype": "C1"}, "LLM+CEDAR": {"sample_name": "GSM8191666", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below", "tissue": "ovary", "disease": "High-grade serous ovarian cancer", "sample_type": "Serous carcinoma", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "biosample_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191768"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_name": "GSM8191768", "disease": "HGSC", "tissue": "Serous carcinoma", "sample_type": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191768", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "serous carcinoma cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185601"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185601", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185601", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192214"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192214", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192214", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C3", "treatment": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185613"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185613", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian neoplasm", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185511"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_type": "Serous carcinoma", "sample_type": "tissue sample", "phenotype": "HGSC", "biomaterial_provider": "GSM8185511", "sample_name": "JGOG3025-TR2", "health_state": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185511", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509201"], "tissue": "Ovary", "roi": "002", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509201", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Ovary", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "GSE276935"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509201", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "002", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192167"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_name": "GSM8192167", "tissue": "Primary tumor", "disease": "HGSC", "cell_type": "Serous carcinoma", "isolate": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192167", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "HGSC", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509380"], "tissue": "Fallopian Tube", "roi": "010", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509380", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Fallopian Tube", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509380", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191837"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191837", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "isolate": "HGSC", "tissue": "Ovarian", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_type": "Cancer cell", "sample_type": "Tissue sample", "disease_stage": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191837", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251956"], "tissue": "Omentum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251956", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "tissue": "Omentum", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients.", "treatment": "Chemo-naive"}, "LLM+CEDAR": {"biosample_accession": "GSM8251956", "sample_name": "NA", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor or ascites samples", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185460"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "primary tumor", "bioproject_accession": "GSE263455"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185460", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509447"], "tissue": "Ovary", "roi": "004", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509447", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "004", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509447", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "disease": "high grade serous ovarian cancer", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Ovary", "cell_type": "NA", "sample_type": "Immune", "treatment": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "isolate": "004", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509266"], "tissue": "Lymph Node", "roi": "005", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509266", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Lymph Node", "cell_line": "", "cell_subtype": "", "cell_type": "Immune", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tissue", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509266", "sample_name": "005", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Lymph Node", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancers", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185504"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185504", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "health_state": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185504", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "primary tumor", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191824"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191824", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "HGSC", "tissue": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191824", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185426"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "Histology cpr: HGSC, Histology iti: Serous carcinoma, Assigned cluster: C1"}, "LLM+CEDAR": {"sample_name": "GSM8185426", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C1", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192191"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192191", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC, Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192191", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Primary tumor", "disease": "Serous carcinoma", "sample_type": "HGSC", "treatment": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "C3", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509203"], "tissue": "Ovary", "roi": "003", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509203", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "female", "tissue": "Ovary", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "Immune", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509203", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "lymphoid", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191812"], "histology_cpr": "HGSC", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191812", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Endometrioid carcinoma", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "C2", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191812", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "HGSC", "cell_subtype": "C2", "cell_type": "Endometrioid carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509521"], "tissue": "Fallopian Tube", "roi": "002", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509521", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Fallopian Tube", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509521", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185451"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "biomaterial_provider": "Not provided", "cell_type": "Serous carcinoma", "sample_type": "Tumor tissue", "description": "This SuperSeries is composed of the SubSeries listed below.", "geo_loc_name": "Not provided", "health_state": "Diseased", "isolate": "GSM8185451", "age": "Not provided", "collection_date": "Not provided", "sex": "Not provided"}, "LLM+CEDAR": {"biosample_accession": "GSM8185451", "sample_name": "NA", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509246"], "tissue": "Ovary", "roi": "006", "type": "Tumor", "batch": "1"}, "LLM": {"sample_name": "GSM8509246", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "sample_type": "Tumor", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509246"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192072"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_name": "GSM8192072", "isolate": "Serous carcinoma"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192072", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "C3", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509264"], "tissue": "Lymph Node", "roi": "004", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509264", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not applicable", "age": "Not applicable", "biomaterial_provider": "Not applicable", "collection_date": "Not applicable", "geo_loc_name": "Not applicable", "sex": "Not applicable", "tissue": "Lymph Node", "cell_line": "Not applicable", "cell_subtype": "Not applicable", "cell_type": "Stroma", "culture_collection": "Not applicable", "dev_stage": "Not applicable", "disease": "high grade serous ovarian cancer", "disease_stage": "Not applicable", "ethnicity": "Not applicable", "health_state": "Not applicable", "karyotype": "Not applicable", "phenotype": "Not applicable", "population": "Not applicable", "race": "Not applicable", "sample_type": "Tissue sample", "treatment": "Not applicable", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509264", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Lymph Node", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "Cancer patient", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509234"], "tissue": "Ovary", "roi": "001", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509234", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509234", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192090"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "disease": "Serous carcinoma"}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8192090", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Serous carcinoma", "population": "NA", "race": "NA", "sample_type": "C1", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509381"], "tissue": "Fallopian Tube", "roi": "011", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509381", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Fallopian Tube", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample", "biomaterial_provider": "Not provided", "age": "Not provided", "isolate": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancers (HGSOC)", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "treatment": "Not provided"}, "LLM+CEDAR": {"biosample_accession": "GSM8509381", "sample_name": "011", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509439"], "tissue": "Fallopian Tube", "roi": "013", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509439", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Human", "tissue": "Fallopian Tube", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509439", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "013", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192152"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192152", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192152", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191647"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8191647", "disease": "HGSC", "tissue": "Serous carcinoma", "sample_type": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191647", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "cell_type": "NA", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "HGSC", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C3", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509336"], "tissue": "Ovary", "roi": "010", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509336", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSM8509336", "sample_name": "1", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "010", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "Immune", "cell_type": "Tertiary lymphoid structures", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "cancer", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185612"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "bioproject_accession": "GSM8185612", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8185612", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191888"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8191888", "disease": "HGSC", "tissue": "Serous carcinoma", "population": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191888", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C3", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192185"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192185", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "C3", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192185", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "ovarian tissue", "disease": "high grade serous ovarian carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191786"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191786", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample", "disease_stage": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191786", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509420"], "tissue": "Omentum", "roi": "012", "type": "Tumor", "batch": "2"}, "LLM": {"sample_name": "GSM8509420", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Tumor", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509420", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509515"], "tissue": "Ovary", "roi": "020", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509515", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509515", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509401"], "tissue": "Omentum", "roi": "001", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509401", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "CD20", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509401", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509579"], "tissue": "Ovary", "roi": "001", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509579", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "001", "age": "not collected", "biomaterial_provider": "not provided", "collection_date": "not collected", "geo_loc_name": "not collected", "sex": "female", "tissue": "Ovary", "cell_line": "not applicable", "cell_subtype": "not applicable", "cell_type": "not applicable", "culture_collection": "not applicable", "dev_stage": "not applicable", "disease": "high grade serous ovarian cancers", "disease_stage": "not collected", "ethnicity": "not collected", "health_state": "diseased", "karyotype": "not collected", "phenotype": "not collected", "population": "not collected", "race": "not collected", "sample_type": "tissue sample", "treatment": "not collected", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509579", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191721"], "histology_cpr": "EndoG3", "histology_iti": "Other", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8191721", "tissue": "EndoG3", "cell_type": "Other", "sample_name": "C4"}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "EndoG3", "cell_type": "C4", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191678"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "bioproject_accession": "GSM8191678", "organism": "HGSC", "tissue": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191678", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Serous carcinoma", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192197"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192197", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Ovarian Cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192197", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C3", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185628"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "Histology CPR: HGSC, Histology ITI: Serous carcinoma, Assigned Cluster: C2"}, "LLM+CEDAR": {"sample_name": "GSM8185628", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509325"], "tissue": "Ovary", "roi": "006", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509325", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Stroma", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509325"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "006", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185594"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_type": "tissue sample", "disease_stage": "HGSC", "cell_type": "Serous carcinoma", "biomaterial_provider": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185594", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185512"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Endometrioid carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_name": "GSM8185512", "health_state": "disease state", "biomaterial_provider": "JGOG3025-TR2 cohort", "cell_type": "Endometrioid carcinoma", "phenotype": "HGSC", "population": "assigned cluster C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185512", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191802"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "sample_type": "tissue sample", "tissue": "HGSC"}, "LLM+CEDAR": {"sample_name": "GSM8191802", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191902"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_name": "GSM8191902", "tissue": "HGSC", "disease": "Serous carcinoma", "cell_type": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191902", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192213"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192213", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8192213", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "ovarian carcinoma cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185471"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_name": "GSM8185471", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8185471", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_type": "Serous carcinoma", "disease_stage": "NA", "sample_type": "HGSC", "treatment": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "cell_line": "NA", "cell_subtype": "C1", "culture_collection": "NA", "dev_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185398"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "isolate": "GSM8185398", "cell_type": "Serous carcinoma", "cell_subtype": "HGSC", "sample_type": "assigned cluster: C2"}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "GSM8185398", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509375"], "tissue": "Fallopian Tube", "roi": "005", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509375", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "biomaterial_provider": "Unknown", "tissue": "Fallopian Tube", "cell_type": "CD20", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509375", "sample_name": "005", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CD20", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "2", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192026"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192026", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": null, "isolate": null, "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Primary tumor", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "Serous carcinoma", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": null, "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192026", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian Cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185547"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_name": "GSM8185547", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "primary tumor", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "not provided", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185547", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185598"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185598", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor sample", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509539"], "tissue": "Ovary", "roi": "002", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509539", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Ovary", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "Immune", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509539", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "ovary", "disease": "high grade serous ovarian cancer", "cell_type": "NA", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Immune", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185346"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_type": "tumor tissue", "isolate": "GSM8185346", "biomaterial_provider": "unknown", "collection_date": "unknown", "geo_loc_name": "unknown", "sex": "female", "age": "unknown", "cell_type": "Serous carcinoma", "disease_stage": "HGSC", "sample_name": "JGOG3025-TR2"}, "LLM+CEDAR": {"biosample_accession": "GSM8185346", "sample_name": "NA", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "primary tumor cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509181"], "tissue": "Omentum", "roi": "004", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509181", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Ovarian cancer patient", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509181", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "004", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509571"], "tissue": "Omentum", "roi": "007", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509571", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Human", "isolate": "007", "tissue": "Omentum", "sample_type": "Tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509571", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191653"], "histology_cpr": "HGSC", "histology_iti": "Other", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191653", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "HGSC", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Not provided", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191653", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185379"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185379", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "primary tumor", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": null, "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185379", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185595"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "cell_type": "Serous carcinoma", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185595", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185400"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "Serous carcinoma", "sample_type": "primary tumor sample", "description": "Sample belong to cluster C3"}, "LLM+CEDAR": {"sample_name": "GSM8185400", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "primary tumor", "biomaterial_provider": "NA", "organism": "Homo sapiens", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "Cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "isolate": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185401"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185401", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185401", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509498"], "tissue": "Ovary", "roi": "003", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509498", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "003", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509498", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509518"], "tissue": "Ovary", "roi": "023", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509518", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "Immune", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509518", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "023", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191859"], "histology_cpr": "HGSC", "histology_iti": "Clear cell carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_name": "GSM8191859", "tissue": "HGSC", "disease": "Clear cell carcinoma", "sample_type": "C4"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191859", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "Clear cell carcinoma", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185586"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "", "tissue": "primary tumor", "disease": "ovarian cancer", "cell_subtype": "Serous carcinoma", "phenotype": "HGSC", "sample_type": "primary tumor", "treatment": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185586", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "HGSC", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191733"], "histology_cpr": "HGSC", "histology_iti": "Other", "assigned_cluster": "-"}, "LLM": {"sample_name": "GSM8191733", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "disease": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191733", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509492"], "tissue": "Omentum", "roi": "012", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509492", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "HGSOC patient", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "Immune", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509492"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Omentum", "disease": "high grade serous ovarian cancer", "cell_type": "NA", "age": "NA", "sex": "NA", "biomaterial_provider": "NA", "isolate": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Immune", "treatment": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509304"], "tissue": "Omentum", "roi": "007", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509304", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Omentum", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509304", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Omentum", "disease": "high grade serous ovarian cancer", "cell_type": "NA", "age": "NA", "sex": "NA", "biomaterial_provider": "NA", "isolate": "007", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "organism": "NA", "cell_line": "NA", "cell_subtype": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509252"], "tissue": "Ovary", "roi": "009", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509252", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509252", "sample_name": "009", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stromal cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous ovarian cancer", "disease_stage": "high grade", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509385"], "tissue": "Omentum", "roi": "001", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509385", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Omentum tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509385", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191966"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191966", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191966", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509563"], "tissue": "Ovary", "roi": "021", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509563", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "cancer tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509563", "sample_name": "021", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185402"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185402", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185402", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509269"], "tissue": "Omentum", "roi": "001", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509269", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "collection_date": "NA", "geo_loc_name": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "Immune", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509269", "sample_name": "001", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509457"], "tissue": "Fallopian Tube", "roi": "001", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509457", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "001", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Fallopian Tube", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509457", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Fallopian Tube", "disease": "high grade serous ovarian cancer", "cell_type": "Immune", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185418"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_name": "GSM8185418", "cell_type": "Serous carcinoma", "phenotype": "C4"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185418", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185344"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "EndoG3", "histology iti": "Other", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185344", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185344", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "C3", "cell_subtype": "EndoG3", "cell_type": "Other", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "primary tumor", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185516"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo Sapiens", "tissue": "primary tumor", "disease": "ovarian cancer", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185516", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509367"], "tissue": "Ovary", "roi": "011", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509367", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509367", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "011", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CD20", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191956"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Human", "tissue": "Primary tumor", "disease": "Endometrioid carcinoma"}, "LLM+CEDAR": {"sample_name": "GSM8191956", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Primary tumor", "disease": "Endometrioid carcinoma", "biosample_accession": "GSE263455", "biomaterial_provider": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "organism": "NA", "isolate": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191827"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191827", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "HGSC", "cell_line": "", "cell_subtype": "", "cell_type": "Serous carcinoma", "culture_collection": "", "dev_stage": "", "disease": "Ovarian Cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Cancer Tissue Sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191827", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185375"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "Serous carcinoma", "sample_type": "tumor"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185375", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Serous carcinoma", "population": "NA", "race": "NA", "sample_type": "C3", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185541"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "Serous carcinoma", "sample_name": "GSM8185541", "phenotype": "HGSC", "sample_type": "C3"}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185436"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "biomaterial_provider": "GSM8185436", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "disease_stage": "HGSC", "phenotype": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185436", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191885"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191885", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "disease": "Serous carcinoma", "disease_stage": "HGSC", "sample_type": "Cancer tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Ovarian", "cell_type": "Cancer cells", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191885", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191787"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191787", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191787", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "ovarian carcinoma cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185485"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "organism": "Homo sapiens", "tissue": "primary tumor", "disease": "ovarian cancer", "sample_type": "tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "Not provided", "isolate": "Not provided", "age": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "treatment": "Not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185485", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191982"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below. Histology CPR: HGSC, Histology ITI: Serous carcinoma, Assigned Cluster: C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191982", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185544"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "N/A", "isolate": "N/A", "age": "N/A", "biomaterial_provider": "N/A", "collection_date": "N/A", "geo_loc_name": "N/A", "sex": "N/A", "tissue": "primary tumor", "cell_line": "N/A", "cell_subtype": "N/A", "cell_type": "N/A", "culture_collection": "N/A", "dev_stage": "N/A", "disease": "ovarian cancer", "disease_stage": "N/A", "ethnicity": "N/A", "health_state": "N/A", "karyotype": "N/A", "phenotype": "N/A", "population": "N/A", "race": "N/A", "sample_type": "N/A", "treatment": "N/A"}, "LLM+CEDAR": {"sample_name": "GSM8185544", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biomaterial_provider": "NA", "tissue": "ovary", "disease": "ovarian neoplasm", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192106"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "disease": "HGSC", "disease_stage": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192106", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304115"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR3", "cell type": "epithelial cells", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours"}, "LLM": {"sample_name": "GSM8304115", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "isolate": "OVCAR3", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR3", "cell_subtype": "", "cell_type": "epithelial cells", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "cell culture", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "GSE268985", "sample_name": "GSM8304115", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "organism": "NA", "tissue": "ovary", "cell_line": "OVCAR3", "cell_type": "epithelial cell", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours", "disease": "high-grade serous ovarian adenocarcinoma", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer.", "bioproject_accession": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191905"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "HGSC", "disease": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8191905", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Ovary", "sample_type": "Tumor", "biomaterial_provider": "NA", "bioproject_accession": "GSE263455", "age": "NA", "sex": "NA", "organism": "Homo sapiens", "isolate": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "biosample_accession": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509346"], "tissue": "Omentum", "roi": "001", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509346", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509346", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192154"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "GSM8192154", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor", "treatment": "Not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192154", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191851"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "HGSC", "sample_type": "Cancer tissue", "phenotype": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8191851", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191744"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_name": "GSM8191744", "tissue": "HGSC", "disease": "Serous carcinoma", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191744", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "carcinoma cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509187"], "tissue": "Omentum", "roi": "006", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509187", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "Stroma", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509187", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "006", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251960"], "tissue": "Omentum", "treatment": "NACT"}, "LLM": {"sample_name": "GSM8251960", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "tissue": "Omentum", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251960", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "T-cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509204"], "tissue": "Ovary", "roi": "003", "type": "Tumor", "batch": "1"}, "LLM": {"sample_name": "GSM8509204", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "sample_type": "Tumor", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509204", "sample_name": "003", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509409"], "tissue": "Omentum", "roi": "006", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509409", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509409", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous ovarian cancer", "disease_stage": "high grade", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191951"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "", "bioproject_accession": "GSE263455", "organism": "", "isolate": "GSM8191951", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "C2", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "Serous carcinoma", "population": "", "race": "", "sample_type": "", "treatment": ""}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191951", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185535"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "sample_name": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185535", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "HGSC", "cell_subtype": "Serous carcinoma", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192226"], "tissue": "Primary tumor", "histology_cpr": "EndoG3", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192226", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "EndoG3", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192226", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "EndoG3", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C3", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185363"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185363", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "Homo sapiens", "disease": "ovarian neoplasm", "tissue": "ovary", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "primary tumor", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "biosample_accession": "GSM8185363", "bioproject_accession": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "ovarian cancer", "karyotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185386"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "EndoG3", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "disease": "ovarian cancer", "cell_line": "GSM8185386", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease_stage": "", "ethnicity": "", "health_state": "", "phenotype": "", "population": "", "sample_type": "", "treatment": "", "sample_name": "EndoG3", "isolate": "Serous carcinoma", "karyotype": "", "race": "", "assigned_cluster": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185386", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "EndoG3", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192162"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Clear cell carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_name": "GSM8192162", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Clear cell carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "assigned_cluster": "C4"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192162", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "Clear cell carcinoma", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C4", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509175"], "tissue": "Omentum", "roi": "002", "type": "Tumor", "batch": "1"}, "LLM": {"sample_name": "GSM8509175", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Tumor", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509175", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "002", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509484"], "tissue": "Omentum", "roi": "008", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509484", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Omentum", "sample_type": "tumor"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509484", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "008", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous ovarian cancer", "disease_stage": "high grade", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "2", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192188"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192188", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "Serous carcinoma", "population": "", "race": "", "sample_type": "C2", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192188", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509364"], "tissue": "Ovary", "roi": "009", "type": "Stroma", "batch": "2"}, "LLM": {"sample_name": "GSM8509364", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "009", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509364"], "sample_title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191811"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191811", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Ovarian", "disease": "Serous carcinoma", "disease_stage": "HGSC", "sample_type": "Cancer tissue", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_type": "Assigned_cluster: C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191811", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "C2", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185434"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185434", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185434", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509543"], "tissue": "Ovary", "roi": "004", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509543", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "Immune", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509543", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185369"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "EndoG3", "histology iti": "Endometrioid carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185369", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease_stage": "EndoG3", "sample_type": "tissue sample", "phenotype": "Endometrioid carcinoma", "biomaterial_provider": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185369", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "primary tumor", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "EndoG3", "cell_type": "Endometrioid carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C3", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304128"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR4", "cell type": "epithelial cells", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours"}, "LLM": {"sample_name": "GSM8304128", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "isolate": "OVCAR4", "age": "not collected", "biomaterial_provider": "not collected", "collection_date": "not collected", "geo_loc_name": "not collected", "sex": "not applicable", "tissue": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR4", "cell_type": "epithelial cells", "culture_collection": "not collected", "dev_stage": "not collected", "disease": "ovarian cancer", "disease_stage": "not collected", "ethnicity": "not collected", "health_state": "not collected", "karyotype": "not collected", "phenotype": "cancerous", "population": "not collected", "race": "not collected", "sample_type": "cell culture", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "GSE268985", "sample_name": "GSM8304128", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "OVCAR4", "cell_subtype": "NA", "cell_type": "epithelial cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191683"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8191683", "tissue": "HGSC", "disease": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191683", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "HGSC", "cell_subtype": "Serous carcinoma", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185353"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "HGSC", "description": "Serous carcinoma", "sample_name": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185353", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C2", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509286"], "tissue": "Omentum", "roi": "005", "type": "Tumor", "batch": "1"}, "LLM": {"sample_name": "GSM8509286", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Omentum", "cell_line": null, "cell_subtype": null, "cell_type": "Tumor", "culture_collection": null, "dev_stage": null, "disease": "High grade serous ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "Tumor", "treatment": null, "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509286", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "005", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Tumor", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509432"], "tissue": "Fallopian Tube", "roi": "006", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509432", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "collection_date": "NA", "geo_loc_name": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509432", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "006", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192196"], "tissue": "Primary tumor", "histology_cpr": "EndoG3", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_name": "GSM8192196", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Endometrioid carcinoma", "disease_stage": "EndoG3", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor tissue", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8192196", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Endometrioid carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "EndoG3", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C4", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185410"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "Serous carcinoma", "sample_name": "GSM8185410"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185410", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C2", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509400"], "tissue": "Omentum", "roi": "015", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509400", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Omentum", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSM8509400", "sample_name": "015", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185551"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185551", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192121"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192121", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192121", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192153"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192153", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not Provided", "isolate": "Not Provided", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Primary tumor", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "Ovarian Cancer", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Primary tumor", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192153", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192011"], "tissue": "Primary tumor", "histology_cpr": "EndoG3", "histology_iti": "Other", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192011", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not Provided", "isolate": "Not Provided", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Primary tumor", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "EndoG3", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Primary tumor", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192011", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "EndoG3", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509360"], "tissue": "Omentum", "roi": "005", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509360", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "005", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509360", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "005", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tertiary lymphoid structures", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509528"], "tissue": "Fallopian Tube", "roi": "008", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509528", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Human", "isolate": "008", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Fallopian Tube", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Full ROI", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509528", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304119"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR4", "cell type": "epithelial cells", "treatment": "DMSO (control)"}, "LLM": {"sample_name": "GSM8304119", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "isolate": "OVCAR4", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not applicable", "tissue": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR4", "cell_subtype": "Not provided", "cell_type": "epithelial cells", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "cell culture", "treatment": "DMSO (control)", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "GSE268985", "sample_name": "GSM8304119", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "OVCAR4", "cell_subtype": "NA", "cell_type": "epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "DMSO (control)", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509319"], "tissue": "Ovary", "roi": "004", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509319", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Ovary", "cell_line": null, "cell_subtype": null, "cell_type": "Stroma", "culture_collection": null, "dev_stage": null, "disease": "high grade serous ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": null, "treatment": null, "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509319", "sample_name": "NA", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185616"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185616", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "not provided", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "primary tumor", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "not provided", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185616", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarium", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509232"], "tissue": "Ovary", "roi": "015", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509232", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Stroma", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509232", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "015", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191789"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "HGSC", "tissue": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191789", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "Ovarian serous carcinoma", "tissue": "Ovary", "sample_type": "HGSC", "phenotype": "C2", "biomaterial_provider": "NA", "sex": "NA", "age": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "organism": "Homo sapiens", "isolate": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509358"], "tissue": "Omentum", "roi": "005", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509358", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509358", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "005", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous ovarian cancer", "disease_stage": "high grade", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185566"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185566", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_type": "Serous carcinoma", "phenotype": "HGSC", "sample_type": "tissue sample", "health_state": "Disease state: ovarian cancer"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185566", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191644"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8191644", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Serous carcinoma", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "C2", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191644", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "C2", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304126"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR4", "cell type": "epithelial cells", "treatment": "500 nM RBN-2397 for 24 hours"}, "LLM": {"sample_name": "GSM8304126", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "isolate": "OVCAR4", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR4", "cell_subtype": "", "cell_type": "epithelial cells", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "cell culture", "treatment": "500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8304126", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "OVCAR4", "cell_subtype": "NA", "cell_type": "epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192193"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Not provided", "treatment": "Not provided", "description": "Serous carcinoma", "sample_name": "GSM8192193"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192193", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185383"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "Histology CPR: HGSC, Histology ITI: Serous carcinoma, Assigned Cluster: C2", "cell_line": "GSM8185383"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185383", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191987"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191987", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "N/A", "isolate": "N/A", "age": "N/A", "biomaterial_provider": "N/A", "collection_date": "N/A", "geo_loc_name": "N/A", "sex": "N/A", "tissue": "Primary tumor", "cell_line": "N/A", "cell_subtype": "N/A", "cell_type": "N/A", "culture_collection": "N/A", "dev_stage": "N/A", "disease": "Ovarian Cancer", "disease_stage": "N/A", "ethnicity": "N/A", "health_state": "N/A", "karyotype": "N/A", "phenotype": "N/A", "population": "N/A", "race": "N/A", "sample_type": "Tumor Sample", "treatment": "N/A", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191987", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "C3", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509221"], "tissue": "Ovary", "roi": "010", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509221", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Ovary", "cell_line": null, "cell_subtype": null, "cell_type": "Stroma", "culture_collection": null, "dev_stage": null, "disease": "high grade serous ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "Tissue", "treatment": null, "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509221"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "010", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509291"], "tissue": "Omentum", "roi": "008", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509291", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509291", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192209"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192209", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Primary tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192209", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021610"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021610", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Human", "cell_type": "HGSOC", "tissue": "Omentum", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": "GSM7021610", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "NA", "organism": "Human", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSOC", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Omental biopsies", "treatment": "Chemotherapy, Anti-stabilin1 antibody, Foxp3-ASO", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT)."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251971"], "tissue": "Omentum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251971", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High-grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor or ascites", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSM8251971", "sample_name": "NA", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "scRNA-seq", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192092"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192092", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Serous carcinoma", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8192092", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192061"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192061", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8192061", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian Cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185452"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185452", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185452", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "tumor cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian neoplasm", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192049"], "tissue": "Primary tumor", "histology_cpr": "EndoG3", "histology_iti": "Other", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8192049", "tissue": "Primary tumor", "disease": "EndoG3", "health_state": "Other", "sample_type": "C4"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192049", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "EndoG3", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C4", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021609"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021609", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "tissue": "Omentum", "cell_type": "HGSOC", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": "GSM7021609", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "NA", "organism": "Human", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSOC", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous ovarian cancer", "disease_stage": "high-grade", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "biopsy", "treatment": "neo-adjuvant chemotherapy", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT)."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191700"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191700", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer Cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "Not provided", "health_state": "Cancer", "karyotype": "Not provided", "phenotype": "Cancer", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue Sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below.", "assigned_cluster": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191700", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509493"], "tissue": "Omentum", "roi": "013", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509493", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Omentum", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "GSE276935"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509493", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "013", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192225"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192225", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "Serous carcinoma", "sample_type": "Primary tumor"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192225", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192176"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192176", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Primary tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSM8192176", "sample_name": "NA", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509215"], "tissue": "Ovary", "roi": "007", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509215", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "bioproject_accession": "GSE276935", "isolate": "007", "tissue": "Ovary", "sample_type": "Stroma", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509215", "sample_name": "GSE276935", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "007", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185497"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "GSM8185497", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8185497", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "primary tumor", "disease_stage": "NA", "age": "NA", "biosample_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "NA", "cell_line": "NA", "cell_subtype": "serous carcinoma", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509351"], "tissue": "Omentum", "roi": "003", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509351", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509351", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509383"], "tissue": "Fallopian Tube", "roi": "013", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509383", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Fallopian Tube", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancers", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509383", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "013", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192025"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192025", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "Serous carcinoma", "biomaterial_provider": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample", "phenotype": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192025", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "UBERON:0002367", "disease": "DOID:2394", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CL:0002321", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021624"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021624", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "tissue": "Omentum", "cell_type": "HGSOC", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": "GSM7021624", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "NA", "organism": "Human", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSOC", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor-infiltrating immune cells", "treatment": "neo-adjuvant chemotherapy", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT)."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192118"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "tissue": "Primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "HGSC", "cell_type": "Serous carcinoma", "isolate": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192118", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192087"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192087", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High-grade serous ovarian cancer (HGSC)", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192087", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C3", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191887"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191887", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "HGSC", "cell_line": "", "cell_subtype": "", "cell_type": "Serous carcinoma", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "phenotype": "", "population": "", "race": "", "sample_type": "C2", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191887", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251949"], "tissue": "Ovary", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251949", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "tissue": "Ovary", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251949", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192174"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Primary tumor", "disease": "HGSC, Serous carcinoma", "sample_type": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192174", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C1", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192047"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192047", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "Human", "tissue": "Primary tumor", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "phenotype": "Not provided", "population": "Not provided", "sample_type": "Tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192047", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "Serous carcinoma", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C2", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185342"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "bioproject_accession": "GSM8185342", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185342", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian neoplasm", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185377"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "bioproject_accession": "GSM8185377", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185377", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509394"], "tissue": "Omentum", "roi": "010", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509394", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Omentum", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509394", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192075"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": null, "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": null, "organism": null, "isolate": null, "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Primary tumor", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": null, "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": null, "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192075", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Endometrioid carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192173"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192173", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192173", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509397"], "tissue": "Omentum", "roi": "012", "type": "Stroma", "batch": "2"}, "LLM": {"sample_name": "GSM8509397", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "012", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "Stroma", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509397", "sample_name": "012", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185362"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185362", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185362", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185621"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": null, "isolate": "GSM8185621", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "primary tumor", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": null, "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below.", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185621", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509475"], "tissue": "Omentum", "roi": "001", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509475", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509475"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "High Grade Serous Ovarian Cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509549"], "tissue": "Ovary", "roi": "008", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509549", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "biomaterial_provider": "Not provided", "tissue": "Ovary", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509549"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "008", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509553"], "tissue": "Ovary", "roi": "012", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509553", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509553", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "012", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185484"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "design": "", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "Histology CPR: HGSC, Histology ITI: Serous carcinoma, Assigned cluster: C3"}, "LLM+CEDAR": {"sample_name": "GSM8185484", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian neoplasm", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509313"], "tissue": "Ovary", "roi": "001", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509313", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Ovary", "cell_type": "Stroma", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509313", "sample_name": "001", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185493"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_name": "GSM8185493"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185493", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Serous carcinoma", "population": "NA", "race": "NA", "sample_type": "assigned cluster", "treatment": "C2", "organism": "NA", "isolate": "NA", "age": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509368"], "tissue": "Ovary", "roi": "011", "type": "Stroma", "batch": "2"}, "LLM": {"sample_name": "GSM8509368", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509368", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "011", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509307"], "tissue": "Omentum", "roi": "008", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509307", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "008", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "Stroma", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509307", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509388"], "tissue": "Omentum", "roi": "004", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509388", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Omentum", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "High grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509388", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Mesenchymal stem cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251970"], "tissue": "Omentum", "treatment": "NACT"}, "LLM": {"sample_name": "GSM8251970", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "tissue": "Omentum", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients.", "treatment": "NACT"}, "LLM+CEDAR": {"biosample_accession": "GSM8251970", "sample_name": "NA", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251947"], "tissue": "Omentum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251947", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Human", "tissue": "Omentum", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251947", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "organism": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor or ascites samples", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509301"], "tissue": "Omentum", "roi": "005", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509301", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509301", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Omentum", "disease": "High grade serous ovarian cancer", "cell_type": "Stroma", "sample_type": "Ovarian tumor", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509422"], "tissue": "Omentum", "roi": "014", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509422", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tumor tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509422", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "014", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CD20", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192010"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192010", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Primary tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192010", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191955"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Other", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191955", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Primary tumor", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8191955", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biosample_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185354"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185354", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185354", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "age": "NA", "sex": "NA", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "isolate": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509237"], "tissue": "Ovary", "roi": "002", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509237", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509237", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "002", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192050"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192050", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": null, "isolate": null, "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Primary tumor", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": null, "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192050", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovarian neoplasm", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185481"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C4"}, "LLM": {"sample_name": "GSM8185481", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSM8185481", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian neoplasm", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "ovarian cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509516"], "tissue": "Ovary", "roi": "021", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509516", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "bioproject_accession": "GSE276935", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Ovary"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509516", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "021", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185449"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Endometrioid carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "HGSC Endometrioid carcinoma assigned cluster: C2"}, "LLM+CEDAR": {"sample_name": "GSM8185449", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease_stage": "NA", "cell_type": "Endometrioid carcinoma", "sample_type": "HGSC", "treatment": "NA", "phenotype": "C2", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "population": "NA", "race": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509531"], "tissue": "Fallopian Tube", "roi": "011", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509531", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Fallopian Tube", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509531", "sample_name": "011", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192212"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "disease": "Serous carcinoma", "sample_name": "GSM8192212"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192212", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191866"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191866", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191866", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191706"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191706", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "Homo sapiens", "disease": "Serous carcinoma", "bioproject_accession": "GSE263455", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "HGSC", "sample_type": "Cancer tissue", "health_state": "Cancer"}, "LLM+CEDAR": {"sample_name": "GSM8191706", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "High-grade serous ovarian carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Ovary", "biomaterial_provider": "NA", "sample_type": "Tumor", "sex": "NA", "age": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "organism": "Homo sapiens", "isolate": "NA", "bioproject_accession": "GSE263455"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191748"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "HGSC", "disease": "Serous carcinoma", "sample_type": "C4"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191748", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509243"], "tissue": "Ovary", "roi": "005", "type": "Tumor", "batch": "1"}, "LLM": {"sample_name": "GSM8509243", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Ovary", "cell_line": null, "cell_subtype": null, "cell_type": "Tumor", "culture_collection": null, "dev_stage": null, "disease": "High grade serous ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "Tumor tissue", "treatment": null, "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509243", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509323"], "tissue": "Ovary", "roi": "006", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509323", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "cell_type": "CD20", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509323", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "006", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CD20", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251961"], "tissue": "Peritoneum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251961", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "tissue": "Peritoneum", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients.", "treatment": "Chemo-naive"}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251961", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Peritoneum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor or ascites samples", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191747"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "cell_type": "HGSC", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191747", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251986"], "tissue": "Omentum", "treatment": "NACT"}, "LLM": {"sample_name": "GSM8251986", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Human", "tissue": "Omentum", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251986", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "T cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021614"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021614", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer", "bioproject_accession": "GSE224392", "organism": "Human", "cell_type": "HGSOC", "tissue": "Omentum", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": "GSM7021614", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "organism": "Human", "tissue": "Omentum", "cell_type": "High-grade serous ovarian cancer", "disease": "High-grade serous ovarian cancer", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype. ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", "sample_type": "NA", "bioproject_accession": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191741"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191741", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "tissue": "Ovarian", "disease": "Serous carcinoma", "health_state": "Diseased", "sample_type": "Tissue sample", "description": "Ovarian cancer sample collected for multi-omics data analysis from the JGOG3025-TR2 cohort. The histology classification is High-Grade Serous Carcinoma (HGSC) and it is assigned to cluster C2."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191741", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185555"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185555", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not Provided", "isolate": "Not Provided", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "primary tumor", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "ovarian cancer", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Not Provided", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185555", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192120"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "bioproject_accession": "GSM8192120", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192120", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "ovarian cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191986"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "organism": "", "bioproject_accession": "GSE263455", "sample_name": "GSM8191986", "tissue": "Primary tumor", "disease": "Serous carcinoma", "phenotype": "HGSC", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191986", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304107"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR3", "cell type": "epithelial cells", "treatment": "DMSO (control)"}, "LLM": {"sample_name": "GSM8304107", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "isolate": "OVCAR3", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR3", "cell_subtype": "Not Provided", "cell_type": "epithelial cells", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "ovarian cancer", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "cell culture", "treatment": "DMSO (control)", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "GSE268985", "sample_name": "GSM8304107", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "OVCAR3", "cell_subtype": "NA", "cell_type": "epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "cell line", "treatment": "DMSO (control)", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192166"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455_GSM8192166", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "C2", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192166", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192007"], "tissue": "Primary tumor", "histology_cpr": "EndoG3", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8192007", "tissue": "Primary tumor", "disease": "Endometrioid carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8192007", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "disease": "Endometrioid carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "EndoG3", "treatment": "NA", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "C2", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509567"], "tissue": "Omentum", "roi": "003", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509567", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tumor tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509567", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191883"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191883", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "ovarian", "disease": "Serous carcinoma", "phenotype": "HGSC", "sample_type": "tumor tissue"}, "LLM+CEDAR": {"sample_name": "GSM8191883", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "High-grade serous ovarian carcinoma", "sample_type": "C2", "biomaterial_provider": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191690"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191690", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191690", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191725"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_name": "GSE263455", "bioproject_accession": "GSM8191725", "organism": "HGSC", "disease": "Serous carcinoma", "dev_stage": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191725", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192186"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192186", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Serous carcinoma", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192186", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021612"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021612", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "tissue": "Omentum", "cell_type": "HGSOC", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": "GSM7021612", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "NA", "organism": "Human", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSOC", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor-infiltrating immune cells", "treatment": "Neo-adjuvant chemotherapy", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype. ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192215"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192215", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "N/A", "age": "N/A", "biomaterial_provider": "N/A", "collection_date": "N/A", "geo_loc_name": "N/A", "sex": "N/A", "tissue": "Primary tumor", "cell_line": "N/A", "cell_subtype": "Serous carcinoma", "cell_type": "HGSC", "culture_collection": "N/A", "dev_stage": "N/A", "disease": "Ovarian Cancer", "disease_stage": "N/A", "ethnicity": "N/A", "health_state": "N/A", "karyotype": "N/A", "phenotype": "N/A", "population": "N/A", "race": "N/A", "sample_type": "tumor", "treatment": "N/A", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192215", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "HGSC", "biomaterial_provider": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191770"], "histology_cpr": "HGSC", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191770", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Endometrioid carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8191770", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "disease": "Endometrioid carcinoma", "cell_type": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "C3", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192216"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192216", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192216", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191775"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Serous carcinoma", "sample_type": "HGSC", "disease": "Ovarian Cancer", "disease_stage": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191775", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "ovarian cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185542"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185542", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185542", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509536"], "tissue": "Ovary", "roi": "001", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509536", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509536", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191780"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "-"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "design": "", "sample_name": "GSE263455", "bioproject_accession": "GSM8191780", "tissue": "HGSC", "disease": "Serous carcinoma", "assigned_cluster": "-"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191780", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191699"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191699", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "HGSC", "sample_type": "cell culture", "cell_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191699", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251981"], "tissue": "Peritoneum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251981", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Female", "tissue": "Peritoneum", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "high-grade serous ovarian cancer", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Tumor sample", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251981", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Peritoneum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509500"], "tissue": "Ovary", "roi": "005", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509500", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Ovary", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509500", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "age": "NA", "sex": "NA", "tissue": "Ovary", "disease": "high grade serous ovarian cancer", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "NA", "isolate": "NA", "biomaterial_provider": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192142"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "JGOG3025-TR2", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "isolate": "GSM8192142", "assigned_cluster": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192142", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509249"], "tissue": "Ovary", "roi": "008", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509249", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "female", "tissue": "Ovary", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "not provided", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "phenotype": "not provided", "population": "not provided", "sample_type": "Tumor", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509249", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "008", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "1", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185491"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_type": "primary tumor"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185491", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185607"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185607", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below. Histology: HGSC (High-grade serous carcinoma), ITI: Serous carcinoma, assigned cluster: C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185607", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509331"], "tissue": "Ovary", "roi": "008", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509331", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509331", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "008", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191756"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "HGSC", "tissue": "Serous carcinoma", "sample_type": "assigned_cluster", "sample_name": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8191756", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "ovary", "disease": "high grade serous ovarian carcinoma", "sample_type": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185589"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185589", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Not provided", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185589", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "HGSC, Serous carcinoma, C3"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185411"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185411", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191809"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191809", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tumor tissue"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191809", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185439"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "organism": "", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_type": "primary tumor", "bioproject_accession": "GSE263455", "isolate": "GSM8185439", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "age": "", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "treatment": "", "sample_name": "HGSC"}, "LLM+CEDAR": {"sample_name": "GSM8185439", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509226"], "tissue": "Ovary", "roi": "013", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509226", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "013", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Ovary", "cell_line": null, "cell_subtype": "CD20", "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "high grade serous ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": null, "treatment": null, "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509226", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "013", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191716"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "phenotype": "HGSC", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191716", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous ovarian carcinoma", "disease_stage": "C2", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191697"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191697", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "HGSC", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "ovarian tissue", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Cancer Cell", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "Serous carcinoma", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Cancer Cluster C2", "population": "Not Provided", "race": "Not Provided", "sample_type": "Cancer Tissue Sample", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191697", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "HGSC", "cell_subtype": "Serous carcinoma", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "C2", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192218"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192218", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8192218", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "tumor cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191783"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191783", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "Ovarian", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8191783", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509589"], "tissue": "Ovary", "roi": "008", "type": "Stroma", "batch": "2"}, "LLM": {"sample_name": "GSM8509589", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509589", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "008", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192066"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192066", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Primary tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192066", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509350"], "tissue": "Omentum", "roi": "002", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509350", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_type": "Stroma", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509350", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191848"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191848", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Serous carcinoma", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "C2", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "NA", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Serous carcinoma", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191655"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "organism": "", "bioproject_accession": "GSE263455", "sample_name": "GSM8191655", "disease": "HGSC", "tissue": "Serous carcinoma", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8191655", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192027"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192027", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192027", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C1", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509238"], "tissue": "Ovary", "roi": "003", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509238", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSM8509238", "sample_name": "003", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "ovary", "disease": "high grade serous ovarian cancer", "sample_type": "CD20", "biomaterial_provider": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191845"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191845", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Serous carcinoma", "cell_line": "", "cell_subtype": "", "cell_type": "HGSC", "culture_collection": "", "dev_stage": "", "disease": "Ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "C1", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8191845", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "GSE263455", "disease": "Ovarian Serous Cystadenocarcinoma", "sample_type": "NA", "treatment": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185602"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease_stage": "", "ethnicity": "", "health_state": "", "phenotype": "", "population": "", "sample_type": "tissue sample", "treatment": "", "sample_name": "GSM8185602", "isolate": "", "race": "", "karyotype": "", "assigned_cluster": "C2", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma"}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biosample_accession": "GSM8185602", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "organism": "NA", "isolate": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192172"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192172", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "", "health_state": "Primary tumor", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Primary tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192172", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191865"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191865", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Ovarian tissue", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "Serous carcinoma", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": "HGSC", "population": null, "race": null, "sample_type": null, "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191865", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509257"], "tissue": "Lymph Node", "roi": "002", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509257", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Lymph Node", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509257", "sample_name": "002", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "1", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Lymph Node", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509349"], "tissue": "Omentum", "roi": "002", "type": "Tumor", "batch": "1"}, "LLM": {"sample_name": "GSM8509349", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "Tumor", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tumor", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509349", "sample_name": "002", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509339"], "tissue": "Ovary", "roi": "011", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509339", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "011", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Ovary", "cell_line": null, "cell_subtype": null, "cell_type": "Immune", "culture_collection": null, "dev_stage": null, "disease": "high grade serous ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "tissue sample", "treatment": null, "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509339", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "age": "NA", "sex": "NA", "tissue": "Ovary", "disease": "high grade serous ovarian cancer", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "NA", "isolate": "NA", "biomaterial_provider": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192028"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8192028", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192028", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185597"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185597", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below. Histology cpr: HGSC, histology iti: Serous carcinoma, assigned cluster: C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185597", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191978"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191978", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "Unknown", "geo_loc_name": "Unknown", "sample_type": "Tumor tissue"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191978", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "C3", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191759"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191759", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "HGSC", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191759", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192019"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8192019", "bioproject_accession": "GSE263455", "organism": "Human", "tissue": "Primary tumor", "cell_type": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "Not provided", "isolate": "Not provided", "age": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "cell_line": "Not provided", "cell_subtype": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Not provided", "treatment": "Not provided"}, "LLM+CEDAR": {"sample_name": "GSM8192019", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biosample_accession": "GSE263455", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "NA", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191684"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191684", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "ovarian", "description": "This SuperSeries is composed of the SubSeries listed below.", "phenotype": "HGSC", "sample_type": "tissue sample"}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "High-grade serous ovarian carcinoma", "biomaterial_provider": "NA", "tissue": "ovary", "disease_stage": "NA", "sample_type": "tumor", "treatment": "NA", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "biosample_accession": "GSM8191684"}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021616"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021616", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Human", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "HGSOC", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high-grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tumor-infiltrating immune cells", "treatment": "neo-adjuvant chemotherapy (NACT)", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": "GSM7021616", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "NA", "organism": "Human", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSOC", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "neo-adjuvant chemotherapy (NACT)", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype. ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185570"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_name": "GSM8185570", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185570", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191757"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_name": "GSM8191757", "tissue": "HGSC", "disease": "Serous carcinoma", "population": "C2"}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8191757", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "ovary", "cell_type": "NA", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "Serous carcinoma", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191674"], "histology_cpr": "EndoG3", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191674", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer cell", "culture_collection": "Not provided", "dev_stage": "Adult", "disease": "Serous carcinoma", "disease_stage": "EndoG3", "ethnicity": "Not provided", "health_state": "Diseased", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8191674", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "ovary", "disease": "ovarian serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "phenotype": "EndoG3", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "C3", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185490"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_name": "GSM8185490", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185490", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191844"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Ovarian", "disease": "Serous carcinoma", "biomaterial_provider": "GSM8191844", "sample_type": "Tumor tissue", "phenotype": "HGSC", "population": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191844", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191745"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191745", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191745", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192031"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Primary tumor", "disease": "Serous carcinoma", "sample_type": "HGSC"}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8192031", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192086"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192086", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "tissue": "Primary tumor", "disease": "Serous carcinoma", "disease_stage": "HGSC", "sample_type": "tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192086", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C2", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251985"], "tissue": "Mesentery", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251985", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Mesentery", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "High-grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tumor", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251985", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Mesentery", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "T-cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191803"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8191803", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "ovarian", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "HGSC", "isolate": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191803", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191677"], "histology_cpr": "HGSC", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191677", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer Cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Endometrioid carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8191677", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "Endometrioid carcinoma", "phenotype": "HGSC", "population": "C3", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509479"], "tissue": "Omentum", "roi": "004", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509479", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not collected", "biomaterial_provider": "not provided", "collection_date": "not collected", "geo_loc_name": "not collected", "sex": "not collected", "tissue": "Omentum", "cell_line": "not collected", "cell_subtype": "not collected", "cell_type": "not collected", "culture_collection": "not collected", "dev_stage": "not collected", "disease": "high grade serous ovarian cancer", "disease_stage": "not collected", "ethnicity": "not collected", "health_state": "not collected", "karyotype": "not collected", "phenotype": "not collected", "population": "not collected", "race": "not collected", "sample_type": "Tissue sample", "treatment": "not collected", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509479", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191880"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191880", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "Human", "biomaterial_provider": "", "isolate": "", "age": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovarian", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "HGSC", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "assigned_cluster": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191880", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509357"], "tissue": "Omentum", "roi": "005", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509357", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509357", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "005", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CD20", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191680"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "sample_type": "tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191680", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "serous carcinoma cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192051"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_name": "GSM8192051", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "HGSC", "cell_type": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Tissue sample", "disease_stage": "C4"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192051", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C4", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191657"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191657", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Ovarian", "cell_line": null, "cell_subtype": null, "cell_type": "Cancer", "culture_collection": null, "dev_stage": null, "disease": "Serous carcinoma", "disease_stage": null, "ethnicity": null, "health_state": "Cancer", "karyotype": null, "phenotype": "HGSC", "population": null, "race": null, "sample_type": "Tissue sample", "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191657", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C3", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185396"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "Histology CPR: HGSC; Histology ITI: Serous carcinoma; Assigned Cluster: C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185396", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "ovarian epithelial cell", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185519"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "GSM8185519", "disease": "ovarian cancer", "tissue": "primary tumor", "disease_stage": "HGSC", "cell_type": "Serous carcinoma", "population": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185519", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian neoplasm", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C2", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021613"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021613", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "HGSOC", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High-grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Omental biopsy", "treatment": "Neo-adjuvant chemotherapy", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": "GSM7021613", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "high-grade serous ovarian cancer", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "Chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies. Identified potential targets that could enhance response to neo-adjuvant chemotherapy (NACT)."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192038"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "disease": "HGSC", "disease_stage": "Serous carcinoma", "sample_type": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192038", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509445"], "tissue": "Ovary", "roi": "003", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509445", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509445", "sample_name": "003", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509242"], "tissue": "Ovary", "roi": "004", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509242", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not collected", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "female", "tissue": "Ovary", "cell_line": "not applicable", "cell_subtype": "not applicable", "cell_type": "Stroma", "culture_collection": "not applicable", "dev_stage": "not applicable", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not collected", "health_state": "diseased", "karyotype": "not collected", "phenotype": "not collected", "population": "not collected", "race": "not collected", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509242"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "004", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "1", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191984"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191984", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191984", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "C3", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "HGSC", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191864"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191864", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191864", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185486"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_name": "GSM8185486", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tumor tissue", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8185486", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian neoplasm", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191796"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191796", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Serous carcinoma", "cell_line": null, "cell_subtype": "HGSC", "cell_type": "C2", "culture_collection": null, "dev_stage": null, "disease": "Ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "Tumor tissue", "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8191796", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509295"], "tissue": "Omentum", "roi": "001", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509295", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509295", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185543"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185543", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185543", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian neoplasm", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185453"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185453", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185453", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian neoplasm", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191658"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "", "bioproject_accession": "GSE263455", "organism": "", "isolate": "GSM8191658", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Serous carcinoma", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "C4", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": ""}, "LLM+CEDAR": {"sample_name": "GSM8191658", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "High-grade serous ovarian carcinoma", "cell_type": "Cancer cell", "biomaterial_provider": "NA", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Ovary", "sample_type": "C4", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304112"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR3", "cell type": "epithelial cells", "treatment": "500 nM RBN-2397 for 24 hours"}, "LLM": {"sample_name": "GSM8304112", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "isolate": "OVCAR3", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR3", "cell_type": "epithelial cells", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "phenotype": "Not provided", "population": "Not provided", "sample_type": "cell culture", "treatment": "500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "GSE268985", "sample_name": "GSM8304112", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "organism": "Homo sapiens", "tissue": "ovary", "disease": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR3", "cell_type": "epithelial cell", "treatment": "500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. This study shows that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, which mimics what was previously observed with PARP7 knockdown. The treatment with RBN-2397 leads to a decrease in growth and migration of ovarian cancer cells, and the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. The study also shows that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes.", "bioproject_accession": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191916"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191916", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian tissue", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191916", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185530"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "-"}, "LLM": {"sample_name": "GSM8185530", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185530", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185510"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "primary tumor", "disease": "ovarian cancer", "sample_type": "tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below. Histology CPR: HGSC. Histology ITI: Serous carcinoma. Assigned cluster: C3."}, "LLM+CEDAR": {"biosample_accession": "GSM8185510", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191899"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191899", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191899", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191925"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "-"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_name": "GSM8191925", "tissue": "HGSC", "disease": "Serous carcinoma", "phenotype": "not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191925", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192046"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192046", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "N/A", "isolate": "N/A", "age": "N/A", "biomaterial_provider": "N/A", "collection_date": "N/A", "geo_loc_name": "N/A", "sex": "N/A", "tissue": "Primary tumor", "cell_line": "N/A", "cell_subtype": "N/A", "cell_type": "N/A", "culture_collection": "N/A", "dev_stage": "N/A", "disease": "HGSC", "disease_stage": "N/A", "ethnicity": "N/A", "health_state": "N/A", "karyotype": "N/A", "phenotype": "N/A", "population": "N/A", "race": "N/A", "sample_type": "Serous carcinoma", "treatment": "N/A", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192046", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192082"], "tissue": "Primary tumor", "histology_cpr": "EndoG3", "histology_iti": "Serous carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8192082", "tissue": "Primary tumor", "disease": "EndoG3", "phenotype": "Serous carcinoma", "sample_type": "C4"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192082", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185381"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "sample_name": "GSM8185381"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185381", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "disease tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185372"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185372", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Not provided", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "organism": "NA", "tissue": "primary tumor", "disease": "ovarian cancer", "sample_type": "Serous carcinoma", "age": "NA", "sex": "NA", "biomaterial_provider": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "isolate": "NA", "bioproject_accession": "NA", "biosample_accession": "GSM8185372"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509550"], "tissue": "Ovary", "roi": "009", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509550", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Ovary", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509550", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "009", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185521"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Other", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "sample_name": "GSM8185521"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185521", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509460"], "tissue": "Fallopian Tube", "roi": "004", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509460", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "004", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Fallopian Tube", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "high grade serous ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "Full ROI", "treatment": null, "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509460", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "004", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509258"], "tissue": "Lymph Node", "roi": "002", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509258", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Lymph Node", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "GSE276935", "isolate": "002"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509258", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Lymph Node", "disease": "high grade serous ovarian cancer", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509485"], "tissue": "Omentum", "roi": "008", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509485", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509485", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Omentum", "disease": "high grade serous ovarian cancer", "cell_type": "NA", "biomaterial_provider": "NA", "sex": "NA", "age": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Immune", "treatment": "NA", "organism": "Homo sapiens", "isolate": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185505"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "sex": "not provided", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_name": "GSM8185505", "cell_type": "Serous carcinoma", "phenotype": "HGSC", "health_state": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185505", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192180"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "organism": "Homo sapiens", "disease": "Serous carcinoma", "population": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192180", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "C2", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191843"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191843", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "HGSC", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "C3", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8191843", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C3", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509437"], "tissue": "Fallopian Tube", "roi": "011", "type": "Tumor", "batch": "2"}, "LLM": {"sample_name": "GSM8509437", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "011", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Fallopian Tube", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Tumor", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Tumor", "treatment": "Not Provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509437", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "011", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509206"], "tissue": "Ovary", "roi": "004", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509206", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509206", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "004", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192063"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192063", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below. Histology CPR: HGSC, Histology ITI: Serous carcinoma, Assigned Cluster: C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192063", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509463"], "tissue": "Fallopian Tube", "roi": "007", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509463", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "007", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Fallopian Tube", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509463", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "007", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021607"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021607", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "cell_type": "HGSOC", "tissue": "Omentum"}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM7021607", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "High-grade serous ovarian cancer", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Omental biopsies", "treatment": "Neo-adjuvant chemotherapy", "description": "Single-cell RNA sequencing conducted on tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185433"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Other", "assigned cluster": "-"}, "LLM": {"sample_name": "GSM8185433", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "disease": "ovarian cancer", "tissue": "primary tumor"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185433", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191720"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191720", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "HGSC", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample", "disease_stage": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191720", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191686"], "histology_cpr": "EndoG3", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191686", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "EndoG3", "cell_type": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "sample_name": "GSM8191686", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "EndoG3", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509436"], "tissue": "Fallopian Tube", "roi": "010", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509436", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Fallopian Tube", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Full ROI", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509436"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "high grade serous ovarian cancer", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191682"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191682", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "cancer cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": ["GSM8191682"], "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "serous carcinoma", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191807"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_type": "GSM8191807", "tissue": "HGSC", "disease": "Serous carcinoma", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191807", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "ovarian epithelial cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509545"], "tissue": "Ovary", "roi": "005", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509545", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509545", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "005", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous ovarian cancer", "disease_stage": "high grade", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251993"], "tissue": "Ascites", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251993", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ascites", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High-grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tumor or ascites samples", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251993", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ascites", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor or ascites samples", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185472"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Endometrioid carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185472", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509444"], "tissue": "Ovary", "roi": "002", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509444", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509444", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "ovary", "disease": "high grade serous ovarian cancer", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251972"], "tissue": "Omentum", "treatment": "NACT"}, "LLM": {"sample_name": "GSM8251972", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High-grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor or ascites samples", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251972", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor or ascites", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191999"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "NA", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "GSM8191999", "age": "NA", "biomaterial_provider": "NA", "collection_date": "NA", "geo_loc_name": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Serous carcinoma", "population": "NA", "race": "NA", "sample_type": "Tumor Sample", "treatment": "NA"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191999", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C1", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191912"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191912", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "isolate": "HGSC", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Serous carcinoma", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Ovarian Cancer", "disease_stage": "C2", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8191912", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "biomaterial_provider": "NA", "cell_type": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "tissue": "ovary", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191965"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191965", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "N/A", "isolate": "N/A", "age": "N/A", "biomaterial_provider": "N/A", "collection_date": "N/A", "geo_loc_name": "N/A", "sex": "N/A", "tissue": "Primary tumor", "cell_line": "N/A", "cell_subtype": "N/A", "cell_type": "N/A", "culture_collection": "N/A", "dev_stage": "N/A", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "N/A", "health_state": "N/A", "karyotype": "N/A", "phenotype": "N/A", "population": "N/A", "race": "N/A", "sample_type": "Tissue sample", "treatment": "N/A", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191965", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C3", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185515"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185515", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8185515", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192101"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192101", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC, Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below.", "assigned_cluster": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8192101", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "tissue": "UBERON:0002367", "disease": "DOID:0050847", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CL:0002327", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191659"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191659", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "cell_type": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Cancer tissue sample", "treatment": "Not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191659", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "tissue": "ovary", "disease": "ovarian serous adenocarcinoma", "cell_type": "serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509305"], "tissue": "Omentum", "roi": "007", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509305", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "Stroma", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509305", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "007", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "1", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185592"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "Serous carcinoma", "sample_name": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "HGSC", "biomaterial_provider": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185592", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian neoplasm", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509524"], "tissue": "Fallopian Tube", "roi": "004", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509524", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "004", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Fallopian Tube", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancers", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509524", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "004", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191913"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovarian Cancer Tissue", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8191913", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "sample_type": "HGSC", "tissue": "ovary", "cell_type": "Serous carcinoma", "phenotype": "C2", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The chromatin landscape of high-grade serous ovarian cancer metastasis identifies potential regulatory drivers of chemoresistant tumour cells"], "summary": ["Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC) but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determined the single cell chromatin accessibility landscape of omental OC metastasis from treatment na\u00efve and neoadjuvant chemotherapy-treated patients and defined the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells displayed open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX. Chemotherapy drove profound tumour heterogeneity and selection for cells with accessible chromatin enriched for TP53, TP63 and resistance-pathway-activating TF motifs. Nuclear receptors RORa, NR2F6 and HNF4NG were identified as candidate transcriptional drivers of stress-associated chemotherapy resistance whilst closure of binding sites for E2F2 and E2F4 indicated low proliferative capacity of resistant tumour subsets. Delineation of the epigenetic landscape of chemoresistant ovarian cancer therefore reveals core transcriptional regulators of chemoresistance and identifies potential novel therapeutic approaches for improving clinical outcome."], "design": "", "gse": "GSE247982", "gsm": ["GSM7904045"], "tissue": "HGSOC Omentum", "cell type": "mixed", "treatment": "treatment-naive"}, "LLM": {"sample_name": "GSM7904045", "sample_title": "The chromatin landscape of high-grade serous ovarian cancer metastasis identifies potential regulatory drivers of chemoresistant tumour cells", "bioproject_accession": "GSE247982", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "HGSOC Omentum", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "mixed", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high-grade serous ovarian cancer", "disease_stage": "metastasis", "ethnicity": "not provided", "health_state": "chemoresistant", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "treatment-naive", "description": "Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC) but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determined the single cell chromatin accessibility landscape of omental OC metastasis from treatment na\u00efve and neoadjuvant chemotherapy-treated patients and defined the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells displayed open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX. Chemotherapy drove profound tumour heterogeneity and selection for cells with accessible chromatin enriched for TP53, TP63 and resistance-pathway-activating TF motifs. Nuclear receptors RORa, NR2F6 and HNF4NG were identified as candidate transcriptional drivers of stress-associated chemotherapy resistance whilst closure of binding sites for E2F2 and E2F4 indicated low proliferative capacity of resistant tumour subsets. Delineation of the epigenetic landscape of chemoresistant ovarian cancer therefore reveals core transcriptional regulators of chemoresistance and identifies potential novel therapeutic approaches for improving clinical outcome."}, "LLM+CEDAR": {"biosample_accession": "GSE247982", "sample_name": ["GSM7904045"], "sample_title": "The chromatin landscape of high-grade serous ovarian cancer metastasis identifies potential regulatory drivers of chemoresistant tumour cells", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "mixed", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "metastasis", "ethnicity": "NA", "health_state": "chemoresistant", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "treatment-naive", "description": "Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC) but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determined the single cell chromatin accessibility landscape of omental OC metastasis from treatment na\u00efve and neoadjuvant chemotherapy-treated patients and defined the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells displayed open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX. Chemotherapy drove profound tumour heterogeneity and selection for cells with accessible chromatin enriched for TP53, TP63 and resistance-pathway-activating TF motifs. Nuclear receptors RORa, NR2F6 and HNF4NG were identified as candidate transcriptional drivers of stress-associated chemotherapy resistance whilst closure of binding sites for E2F2 and E2F4 indicated low proliferative capacity of resistant tumour subsets. Delineation of the epigenetic landscape of chemoresistant ovarian cancer therefore reveals core transcriptional regulators of chemoresistance and identifies potential novel therapeutic approaches for improving clinical outcome."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185533"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below. Histology CPR: HGSC, Histology ITI: Serous carcinoma, Assigned Cluster: C1", "sample_name": "GSM8185533"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185533", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "age": "NA", "organism": "NA", "isolate": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185463"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "cell_type": "Serous carcinoma", "sample_type": "tumor"}, "LLM+CEDAR": {"sample_name": "GSM8185463", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_type": "NA", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509478"], "tissue": "Omentum", "roi": "003", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509478", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509478", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509575"], "tissue": "Omentum", "roi": "012", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509575", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Omentum", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "not provided", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509575", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191769"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191769", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "HGSC", "disease_stage": "C3", "tissue": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191769", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "serous carcinoma cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191667"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8191667", "disease": "Serous carcinoma", "bioproject_accession": "GSE263455", "cell_type": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191667", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "ovarian carcinoma cell", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021620"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021620", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "cell_type": "HGSOC", "tissue": "Omentum", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": "GSM7021620", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "NA", "organism": "Human", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSOC", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor-infiltrating immune cells", "treatment": "Neo-adjuvant chemotherapy, anti-stabilin1 antibody, Foxp3-ASO", "description": "Single-cell RNA sequencing of tumor-infiltrating immune cells in high-grade serous ovarian cancer omental biopsies. Analysis identified NACT-induced overexpression of stabilin-1 on macrophages and FOXP3 in Tregs. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide repolarised Tregs to an effector T cell phenotype. Syngeneic mouse model data validated these findings. Anti-stabilin1 antibody and Foxp3-ASO increased survival in mice and improved chemotherapy response."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192201"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192201", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192201", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185417"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "Serous carcinoma", "sample_type": "HGSC", "isolate": "GSM8185417"}, "LLM+CEDAR": {"biosample_accession": "GSM8185417", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192221"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "disease": "Serous carcinoma", "sample_type": "HGSC"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192221", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovarian Tissue", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185532"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8185532", "bioproject_accession": "GSE263455", "organism": null, "isolate": null, "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "primary tumor", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": null, "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185532", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "HGSC", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C2", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509347"], "tissue": "Omentum", "roi": "001", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509347", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509347", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192048"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192048", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "Serous carcinoma", "bioproject_accession": "GSE263455", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample", "health_state": "HGSC", "phenotype": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192048", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "C3", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509348"], "tissue": "Omentum", "roi": "001", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509348", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Omentum", "cell_type": "Stroma", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509348", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185506"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample", "disease_stage": "HGSC", "cell_type": "Serous carcinoma", "biomaterial_provider": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185506", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509505"], "tissue": "Ovary", "roi": "010", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509505", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509505", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "010", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "Immune", "cell_type": "B cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185614"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185614", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSM8185614", "sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "primary tumor", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191705"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191705", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191705", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor sample", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191760"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Human", "isolate": "GSM8191760", "tissue": "Serous carcinoma", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "cell_line": "HGSC", "cell_subtype": "Not provided", "cell_type": "Cancer", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Ovarian Cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Not provided"}, "LLM+CEDAR": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "GSE263455", "sample_name": "GSM8191760", "tissue": "ovary", "disease": "high grade serous ovarian carcinoma", "sample_type": "NA", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185525"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Other", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_type": "tissue sample", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "GSM8185525", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "primary tumor", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "ovarian cancer", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185525", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185387"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "EndoG3", "histology iti": "Endometrioid carcinoma", "assigned cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "EndoG3", "sample_type": "Endometrioid carcinoma", "isolate": "C4"}, "LLM+CEDAR": {"sample_name": "GSM8185387", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "ovary", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_type": "Endometrioid carcinoma", "phenotype": "EndoG3", "sample_type": "primary tumor", "disease_stage": "C4", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509195"], "tissue": "Omentum", "roi": "009", "type": "Tumor", "batch": "1"}, "LLM": {"sample_name": "GSM8509195", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "bioproject_accession": "GSE276935", "tissue": "Omentum", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "Tumor", "isolate": "009", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancers", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "treatment": "Not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509195", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "009", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191853"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191853", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "isolate": "JGOG3025-TR2", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Ovarian", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Cancer Cell", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "Serous carcinoma", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Cancer", "karyotype": "Not Provided", "phenotype": "HGSC", "population": "Not Provided", "race": "Not Provided", "sample_type": "Tissue Sample", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8191853", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "C3", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191662"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191662", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "treatment": "Not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191662", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509466"], "tissue": "Fallopian Tube", "roi": "010", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509466", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "bioproject_accession": "GSE276935", "bio_material_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Fallopian Tube", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "Immune", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509466", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Human", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191992"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191992", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "JGOG3025-TR2", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Primary tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191992", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian Cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251958"], "tissue": "Omentum", "treatment": "NACT"}, "LLM": {"sample_name": "GSM8251958", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High-grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor or ascites samples", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251958", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "T-cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509173"], "tissue": "Omentum", "roi": "001", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509173", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Omentum", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "CD20", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "none", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509173", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185423"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_name": "GSM8185423", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185423", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185404"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "EndoG3", "histology iti": "Endometrioid carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "cell_subtype": "EndoG3", "cell_type": "Endometrioid carcinoma", "sample_type": "tumor tissue", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185404", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "Endometrioid carcinoma", "cell_type": "EndoG3", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509540"], "tissue": "Ovary", "roi": "003", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509540", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Ovary", "cell_line": "not applicable", "cell_subtype": "not applicable", "cell_type": "CD20", "culture_collection": "not applicable", "dev_stage": "not applicable", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509540", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "ovary", "disease": "high grade serous ovarian cancer", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191804"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8191804", "tissue": "HGSC", "disease": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191804", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192081"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "GSM8192081", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Serous carcinoma", "treatment": "Not provided", "sample_name": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8192081", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biosample_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185522"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Endometrioid carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "Assigned cluster: C2", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "Endometrioid carcinoma"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185522", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "C2", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191846"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191846", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "Ovarian", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Tumor tissue"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "NA", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "High-grade serous ovarian carcinoma", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021605"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021605", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "HGSOC", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High-grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Chemotherapy and Immunotherapy", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": "GSM7021605", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "NA", "organism": "Human", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSOC", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "neo-adjuvant chemotherapy", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype. ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191920"], "histology_cpr": "EndoG3", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "bioproject_accession": "GSM8191920", "organism": "EndoG3", "disease": "Endometrioid carcinoma", "cluster": "C4"}, "LLM+CEDAR": {"sample_name": "GSM8191920", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biosample_accession": "GSE263455", "disease": "Endometrioid carcinoma", "sample_type": "C4", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "EndoG3", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185619"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_name": "GSM8185619", "disease": "ovarian cancer", "tissue": "primary tumor", "cell_type": "Serous carcinoma", "population": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185619", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185482"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C4"}, "LLM": {"sample_name": "GSM8185482", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185482", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509433"], "tissue": "Fallopian Tube", "roi": "007", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509433", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Fallopian Tube", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509433", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Fallopian Tube", "disease": "high grade serous ovarian cancer", "cell_type": "NA", "age": "NA", "sex": "NA", "biomaterial_provider": "NA", "organism": "NA", "isolate": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191702"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8191702", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "sample_type": "tumor tissue", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191702", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "C2", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191871"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "sample_type": "C1", "sample_name": "GSM8191871"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191871", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191919"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "-"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "HGSC", "cell_type": "Serous carcinoma"}, "LLM+CEDAR": {"sample_name": "GSM8191919", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509461"], "tissue": "Fallopian Tube", "roi": "005", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509461", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not specified", "biomaterial_provider": "Not specified", "collection_date": "Not specified", "geo_loc_name": "Not specified", "sex": "Not specified", "tissue": "Fallopian Tube", "cell_line": "Not specified", "cell_subtype": "Not specified", "cell_type": "Immune", "culture_collection": "Not specified", "dev_stage": "Not specified", "disease": "high grade serous ovarian cancer", "disease_stage": "Not specified", "ethnicity": "Not specified", "health_state": "Not specified", "karyotype": "Not specified", "phenotype": "Not specified", "population": "Not specified", "race": "Not specified", "sample_type": "Tissue sample", "treatment": "Not specified", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509461", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509379"], "tissue": "Fallopian Tube", "roi": "009", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509379", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Fallopian Tube", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509379", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "fallopian tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191714"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191714", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Serous carcinoma", "cell_line": "", "cell_subtype": "", "cell_type": "HGSC", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "C2", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8191714", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509356"], "tissue": "Omentum", "roi": "004", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509356", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Omentum", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "Stroma", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "Tumor tissue", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509356", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "004", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191710"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191710", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "disease": "Serous carcinoma", "health_state": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Ovarian cancer tissue", "sample_type": "Tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191710", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "serous carcinoma cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185462"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "cell_type": "Serous carcinoma", "sample_type": "primary tumor", "description": "Sample from a patient with ovarian cancer, Histology indicates High-Grade Serous Carcinoma (HGSC). Sample is assigned to cluster C2."}, "LLM+CEDAR": {"sample_name": "GSM8185462", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509544"], "tissue": "Ovary", "roi": "005", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509544", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "005", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509544", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "005", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191904"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191904", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "HGSC", "sample_type": "tissue sample"}, "LLM+CEDAR": {"sample_name": "GSM8191904", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185573"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "Histology: HGSC, Serous carcinoma, Assigned cluster: C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "NA", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304116"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR3", "cell type": "epithelial cells", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours"}, "LLM": {"sample_name": "GSM8304116", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "isolate": "OVCAR3", "biomaterial_provider": "Unknown", "collection_date": "Unknown", "geo_loc_name": "Unknown", "sex": "Unknown", "tissue": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR3", "cell_type": "epithelial cells", "culture_collection": "Unknown", "dev_stage": "Unknown", "disease": "ovarian cancer", "disease_stage": "Unknown", "ethnicity": "Unknown", "health_state": "cancer", "phenotype": "Unknown", "population": "Unknown", "sample_type": "cell culture", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "GSE268985", "sample_name": "GSM8304116", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "OVCAR3", "cell_subtype": "NA", "cell_type": "epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "high-grade serous ovarian adenocarcinoma", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509315"], "tissue": "Ovary", "roi": "002", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509315", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Ovary", "cell_line": null, "cell_subtype": null, "cell_type": "Stroma", "culture_collection": null, "dev_stage": null, "disease": "high grade serous ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "tissue sample", "treatment": null, "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509315", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191671"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "sample_type": "tumor tissue", "description": "HGSC ovarian cancer sample, assigned to cluster C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191671", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "cell_type": "NA", "tissue": "ovary", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509198"], "tissue": "Ovary", "roi": "001", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509198", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "001", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Ovary", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "Immune", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509198", "sample_name": "001", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509452"], "tissue": "Ovary", "roi": "009", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509452", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "biomaterial_provider": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Ovary", "sample_type": "Tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509452", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "009", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "B cell", "cell_type": "lymphoid", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192165"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "N/A", "isolate": "N/A", "age": "N/A", "biomaterial_provider": "N/A", "collection_date": "N/A", "geo_loc_name": "N/A", "sex": "N/A", "tissue": "Primary tumor", "cell_line": "N/A", "cell_subtype": "N/A", "cell_type": "N/A", "culture_collection": "N/A", "dev_stage": "N/A", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "N/A", "health_state": "N/A", "karyotype": "N/A", "phenotype": "N/A", "population": "N/A", "race": "N/A", "sample_type": "N/A", "treatment": "N/A", "sample_name": "GSM8192165"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192165", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191701"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191701", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "disease_stage": "HGSC", "sample_type": "Tissue", "description": "This SuperSeries is composed of the SubSeries listed below.", "assigned_cluster": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8191701", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biosample_accession": "GSE263455", "disease": "High grade serous ovarian carcinoma", "phenotype": "C2", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "ovary", "disease_stage": "NA", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509327"], "tissue": "Ovary", "roi": "007", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509327", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "Immune", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509327", "sample_name": "007", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185390"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "primary tumor", "disease": "ovarian cancer", "bioproject_accession": "GSE263455", "cell_line": "GSM8185390", "phenotype": "HGSC", "cell_subtype": "Serous carcinoma", "population": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185390", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "primary tumor", "karyotype": "HGSC", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192207"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192207", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192207", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191695"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Ovarian", "disease": "Serous carcinoma", "sample_type": "Tumor sample", "phenotype": "HGSC", "cell_type": "Cancer cell", "health_state": "Cancer"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191695", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185360"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185360", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8185360", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "HGSC", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192035"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192035", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192035", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian Cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191838"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191838", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "Ovarian", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_type": "HGSC", "sample_type": "tumor sample", "health_state": "Cancer", "biomaterial_provider": "Unknown", "cell_line": "Not applicable"}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "NA", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191854"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191854", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191854", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "C2", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192023"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "Serous carcinoma", "population": "", "race": "", "sample_type": "C1", "treatment": "", "sample_name": "GSM8192023"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192023", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "HGSC", "cell_subtype": "Serous carcinoma", "cell_type": "C1", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185361"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "health_state": "diseased", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample", "biomaterial_provider": "Not provided", "isolate": "GSM8185361", "age": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "female", "disease_stage": "Not provided", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "ethnicity": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "treatment": "Not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185361", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185450"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_name": "GSM8185450", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "population": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185450", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "age": "NA", "sex": "NA", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "isolate": "NA", "biomaterial_provider": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191661"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_name": "GSM8191661", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "High-grade serous carcinoma (HGSC)", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191661", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "serous carcinoma", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251973"], "tissue": "Omentum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251973", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "high-grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor or ascites samples", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": ["GSM8251973"], "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021604"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021604", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Omentum", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "HGSOC", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high-grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tumor-infiltrating immune cells", "treatment": "neo-adjuvant chemotherapy (NACT)", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"sample_name": "GSM7021604", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "high-grade serous ovarian cancer cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "biopsy", "treatment": "neo-adjuvant chemotherapy, STAB1 inhibition, FOXP3 anti-sense oligonucleotide", "description": "Single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT)."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185569"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_type": "tumor", "organism": "Homo sapiens"}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8185569", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509565"], "tissue": "Omentum", "roi": "001", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509565", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509565", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509344"], "tissue": "Ovary", "roi": "015", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509344", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509344", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185501"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185501", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8185501", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "tissue": "primary tumor", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "isolate": "NA", "age": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192107"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192107", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "tissue": "Primary tumor", "disease": "Serous carcinoma", "biomaterial_provider": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Tumor tissue", "health_state": "Cancer", "phenotype": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8192107", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Primary tumor", "disease": "Serous carcinoma", "sample_type": "HGSC", "biomaterial_provider": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "age": "NA", "sex": "NA", "organism": "NA", "isolate": "NA", "bioproject_accession": "GSE263455", "biosample_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191898"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191898", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "cell_type": "Cancer Cell", "disease": "Ovarian Cancer", "disease_stage": "HGSC", "tissue": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191898", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191849"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191849", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "Ovarian", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191849", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191673"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_name": "GSM8191673", "disease": "HGSC", "tissue": "Serous carcinoma", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191673", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192205"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "HGSC", "cell_type": "Serous carcinoma"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192205", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Serous carcinoma", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509205"], "tissue": "Ovary", "roi": "003", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509205", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Ovary", "sample_type": "Stroma", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509205", "sample_name": "003", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185364"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "-"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "sample_type": "tumor sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185364", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509551"], "tissue": "Ovary", "roi": "010", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509551", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Ovary", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509551"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509487"], "tissue": "Omentum", "roi": "009", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509487", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Omentum", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509487", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191753"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191753", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "health_state": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191753", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192033"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192033", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509423"], "tissue": "Omentum", "roi": "014", "type": "Other", "batch": "2"}, "LLM": {"sample_name": "GSM8509423", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509423", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Omentum", "disease": "high grade serous ovarian cancer", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Other", "treatment": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509526"], "tissue": "Fallopian Tube", "roi": "006", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509526", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Fallopian Tube", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509526", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192169"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192169", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": null, "isolate": null, "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Primary tumor", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "HGSC, Serous carcinoma", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": null, "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8192169", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_type": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "cell_type": "Serous carcinoma", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "C1", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509566"], "tissue": "Omentum", "roi": "002", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509566", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tumor", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509566"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "002", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509174"], "tissue": "Omentum", "roi": "001", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509174", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "001", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Female", "tissue": "Omentum", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Immune", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "High grade serous ovarian cancers", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Tissue Sample", "treatment": "Not Provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509174", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Omentum", "disease": "high grade serous ovarian cancer", "cell_type": "NA", "age": "NA", "sex": "NA", "biomaterial_provider": "NA", "organism": "NA", "isolate": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509248"], "tissue": "Ovary", "roi": "008", "type": "Tumor", "batch": "1"}, "LLM": {"sample_name": "GSM8509248", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Ovary", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Tumor", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Tumor", "treatment": "Not Provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509248", "sample_name": "008", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "ovary", "disease": "high grade serous ovarian cancer", "sample_type": "Tumor", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "age": "NA", "isolate": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509443"], "tissue": "Ovary", "roi": "001", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509443", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509443", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509222"], "tissue": "Ovary", "roi": "011", "type": "Tumor", "batch": "1"}, "LLM": {"sample_name": "GSM8509222", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "Tumor", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tumor", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509222", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "011", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509552"], "tissue": "Ovary", "roi": "011", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509552", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509552", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192164"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192164", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8192164", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "HGSC", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509191"], "tissue": "Omentum", "roi": "007", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509191", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509191", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "Homo sapiens", "tissue": "Omentum", "disease": "high grade serous ovarian cancer", "cell_type": "B cells", "sample_type": "Stroma", "biomaterial_provider": "NA", "sex": "NA", "isolate": "NA", "age": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191850"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Serous carcinoma", "sample_type": "HGSC", "sample_name": "GSM8191850"}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8191850", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "NA", "cell_type": "Serous carcinoma", "sample_type": "HGSC", "biomaterial_provider": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "isolate": "NA", "organism": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509482"], "tissue": "Omentum", "roi": "006", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509482", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "collection_date": "NA", "geo_loc_name": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue sample", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509482", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509310"], "tissue": "Omentum", "roi": "009", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509310", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Omentum", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "not provided", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "Stroma", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509310", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Omentum", "disease": "High-grade serous ovarian cancer", "sample_type": "Stroma", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509369"], "tissue": "Ovary", "roi": "012", "type": "Stroma", "batch": "2"}, "LLM": {"sample_name": "GSM8509369", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "Stroma", "culture_collection": "", "dev_stage": "", "disease": "High grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tumor tissue", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509369", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "012", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185554"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185554", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tumor tissue", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185554", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192227"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Other", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "Not provided", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "GSM8192227", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Primary tumor", "treatment": "Not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192227", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185509"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "bioproject_accession": "GSM8185509", "organism": "Homo sapiens", "isolate": "Patient with ovarian cancer", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185509", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185611"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "primary tumor", "disease": "ovarian cancer", "sample_type": "tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below.", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "sample_name": "GSM8185611", "population": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185611", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_type": "Serous carcinoma", "phenotype": "HGSC", "treatment": "C2", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "population": "NA", "race": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509569"], "tissue": "Omentum", "roi": "005", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509569", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Omentum", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509569", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "005", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191788"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_name": "GSM8191788", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovarian", "cell_line": "", "cell_subtype": "", "cell_type": "Cancer", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191788", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185459"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "primary tumor", "bioproject_accession": "GSE263455"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185459", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509404"], "tissue": "Omentum", "roi": "002", "type": "Other", "batch": "2"}, "LLM": {"sample_name": "GSM8509404", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Omentum", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "tissue sample", "treatment": "Not Provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509404", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "omental fat pad", "disease": "high grade serous ovarian cancer", "cell_type": "NA", "organism": "Homo sapiens", "sex": "NA", "age": "NA", "biomaterial_provider": "NA", "isolate": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Other", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185384"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "Histology cpr: HGSC, Histology iti: Serous carcinoma, Assigned cluster: C3"}, "LLM+CEDAR": {"sample_name": "GSM8185384", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "primary tumor", "disease": "ovarian cancer", "sample_type": "Serous carcinoma", "population": "C3", "biomaterial_provider": "NA", "age": "NA", "organism": "NA", "isolate": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "race": "NA", "treatment": "NA", "biosample_accession": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191664"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "sample_name": "GSM8191664", "tissue": "HGSC", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191664", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian Cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C2", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": ["This SuperSeries is composed of the SubSeries listed below."]}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251976"], "tissue": "Omentum", "treatment": "NACT"}, "LLM": {"sample_name": "GSM8251976", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high-grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tumor or ascites samples", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251976", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "T-cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor or ascites samples", "treatment": "neoadjuvant chemotherapy", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191815"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8191815", "disease": "HGSC", "tissue": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "sample_type": "Serous carcinoma", "tissue": "ovary", "biomaterial_provider": "NA", "biosample_accession": "GSM8191815", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191914"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "cell_type": "Serous carcinoma", "disease": "HGSC", "sample_name": "GSM8191914", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191914", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "tumor cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191816"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191816", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "Human", "disease": "Serous carcinoma", "bioproject_accession": "GSE263455", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "HGSC", "sample_type": "C3"}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8191816", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "ovary", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "sample_type": "C3", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509520"], "tissue": "Fallopian Tube", "roi": "002", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509520", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Fallopian Tube", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509520", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "002", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509362"], "tissue": "Omentum", "roi": "006", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509362", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509362", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "006", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185419"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_type": "Serous carcinoma", "biomaterial_provider": "HGSC", "sample_type": "primary tumor", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSM8185419", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192229"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "-"}, "LLM": {"sample_name": "GSM8192229", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not Provided", "isolate": "Not Provided", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Primary tumor", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "Serous carcinoma", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "HGSC", "population": "Not Provided", "race": "Not Provided", "sample_type": "Primary tumor", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8192229", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Primary tumor", "disease": "Serous carcinoma", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "HGSC", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "age": "NA", "organism": "NA", "isolate": "NA", "bioproject_accession": "GSE263455", "biosample_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185563"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C4"}, "LLM": {"sample_name": "GSM8185563", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8185563", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191834"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191834", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Serous carcinoma", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "C2", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191834", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509568"], "tissue": "Omentum", "roi": "004", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509568", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Omentum", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "not provided", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "Omentum tissue", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509568", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185447"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSE263455", "bioproject_accession": "GSM8185447", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185447", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191654"], "histology_cpr": "HGSC", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_name": "GSM8191654", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "JGOG3025-TR2", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovarian", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Endometrioid carcinoma", "disease_stage": "HGSC", "ethnicity": "", "health_state": "Cancer", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191654", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191829"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8191829", "disease": "Serous carcinoma", "cell_type": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455"}, "LLM+CEDAR": {"sample_name": "GSM8191829", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "cell_type": "NA", "tissue": "ovary", "sample_type": "Serous carcinoma", "treatment": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191776"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191776", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "ovarian", "disease": "Serous carcinoma", "sample_type": "tumor tissue", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191776", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "serous carcinoma cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191949"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "SuperSeries composed of SubSeries", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "GSM8191949", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "HGSC", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue sample", "treatment": "Not provided", "sample_name": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191949", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192003"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192003", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "tissue": "Primary tumor", "disease": "HGSC, Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "phenotype": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192003", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192115"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "tissue": "Primary tumor", "disease": "Endometrioid carcinoma", "disease_stage": "HGSC", "sample_type": "tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below.", "isolate": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192115", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Endometrioid carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509287"], "tissue": "Omentum", "roi": "005", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509287", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "biomaterial_provider": "Unknown", "tissue": "Omentum", "sample_type": "Tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509287", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "1", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509240"], "tissue": "Ovary", "roi": "003", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509240", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Stroma", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509240", "sample_name": "003", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509491"], "tissue": "Omentum", "roi": "012", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509491", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "012", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "CD20", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancers", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509491", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191726"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191726", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "ovarian cancer tissue", "cell_type": "cancer cell", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191726", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509193"], "tissue": "Omentum", "roi": "008", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509193", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Omentum", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "Tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509193", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509317"], "tissue": "Ovary", "roi": "003", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509317", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "bioproject_accession": "GSE276935", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Ovary", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "Immune", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509317", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509354"], "tissue": "Omentum", "roi": "003", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509354", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509354", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous ovarian cancer", "disease_stage": "high grade", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509200"], "tissue": "Ovary", "roi": "002", "type": "Tumor", "batch": "1"}, "LLM": {"sample_name": "GSM8509200", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "002", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not applicable", "cell_subtype": "Not applicable", "cell_type": "Tumor", "culture_collection": "Not applicable", "dev_stage": "Not applicable", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509200", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "disease": "high grade serous ovarian cancer", "tissue": "ovary", "sample_type": "Tumor", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "bioproject_accession": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The chromatin landscape of high-grade serous ovarian cancer metastasis identifies potential regulatory drivers of chemoresistant tumour cells"], "summary": ["Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC) but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determined the single cell chromatin accessibility landscape of omental OC metastasis from treatment na\u00efve and neoadjuvant chemotherapy-treated patients and defined the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells displayed open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX. Chemotherapy drove profound tumour heterogeneity and selection for cells with accessible chromatin enriched for TP53, TP63 and resistance-pathway-activating TF motifs. Nuclear receptors RORa, NR2F6 and HNF4NG were identified as candidate transcriptional drivers of stress-associated chemotherapy resistance whilst closure of binding sites for E2F2 and E2F4 indicated low proliferative capacity of resistant tumour subsets. Delineation of the epigenetic landscape of chemoresistant ovarian cancer therefore reveals core transcriptional regulators of chemoresistance and identifies potential novel therapeutic approaches for improving clinical outcome."], "design": "", "gse": "GSE247982", "gsm": ["GSM7904049"], "tissue": "HGSOC Omentum", "cell type": "mixed", "treatment": "treatment-naive"}, "LLM": {"sample_name": "GSM7904049", "sample_title": "The chromatin landscape of high-grade serous ovarian cancer metastasis identifies potential regulatory drivers of chemoresistant tumour cells", "bioproject_accession": "GSE247982", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "HGSOC Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "mixed", "culture_collection": "", "dev_stage": "", "disease": "high-grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "treatment-naive", "description": "Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC) but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determined the single cell chromatin accessibility landscape of omental OC metastasis from treatment na\u00efve and neoadjuvant chemotherapy-treated patients and defined the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells displayed open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX. Chemotherapy drove profound tumour heterogeneity and selection for cells with accessible chromatin enriched for TP53, TP63 and resistance-pathway-activating TF motifs. Nuclear receptors RORa, NR2F6 and HNF4NG were identified as candidate transcriptional drivers of stress-associated chemotherapy resistance whilst closure of binding sites for E2F2 and E2F4 indicated low proliferative capacity of resistant tumour subsets. Delineation of the epigenetic landscape of chemoresistant ovarian cancer therefore reveals core transcriptional regulators of chemoresistance and identifies potential novel therapeutic approaches for improving clinical outcome."}, "LLM+CEDAR": {"biosample_accession": "GSE247982", "sample_name": "GSM7904049", "sample_title": "The chromatin landscape of high-grade serous ovarian cancer metastasis identifies potential regulatory drivers of chemoresistant tumour cells", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Epithelial cells, Fibroblast, Myeloid cells, Lymphoid cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "Metastasis", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Chemoresistant", "population": "NA", "race": "NA", "sample_type": "Tumour", "treatment": "Treatment-naive", "description": "Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC) but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determined the single cell chromatin accessibility landscape of omental OC metastasis from treatment na\u00efve and neoadjuvant chemotherapy-treated patients and defined the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells displayed open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX. Chemotherapy drove profound tumour heterogeneity and selection for cells with accessible chromatin enriched for TP53, TP63 and resistance-pathway-activating TF motifs. Nuclear receptors RORa, NR2F6 and HNF4NG were identified as candidate transcriptional drivers of stress-associated chemotherapy resistance whilst closure of binding sites for E2F2 and E2F4 indicated low proliferative capacity of resistant tumour subsets. Delineation of the epigenetic landscape of chemoresistant ovarian cancer therefore reveals core transcriptional regulators of chemoresistance and identifies potential novel therapeutic approaches for improving clinical outcome."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185625"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "HGSC, Serous carcinoma", "description": "Assigned to cluster C2 in the study."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185625", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192132"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192132", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Serous carcinoma", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8192132", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "C2", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191735"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_name": "GSM8191735", "disease": "HGSC", "tissue": "Serous carcinoma", "cell_subtype": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191735", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "C3", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Serous carcinoma", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191855"], "histology_cpr": "HGSC", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_name": "GSM8191855", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "disease": "Endometrioid carcinoma", "phenotype": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Cancer Tissue Sample", "tissue": "Ovarian", "disease_stage": "C4"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191855", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Endometrioid carcinoma", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191810"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191810", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "disease_stage": "HGSC", "sample_type": "Tumor tissue", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_type": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191810", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509391"], "tissue": "Omentum", "roi": "007", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509391", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not determined", "tissue": "Omentum", "cell_line": "not applicable", "cell_subtype": "not applicable", "cell_type": "not applicable", "culture_collection": "not applicable", "dev_stage": "not applicable", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509391", "sample_name": "NA", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192187"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192187", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Ovarian Cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Not provided", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8192187", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191708"], "histology_cpr": "EndoG3", "histology_iti": "Other", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "EndoG3", "tissue": "Ovarian", "sample_type": "Tumor", "cell_type": "Cancer"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191708", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "NA", "cell_line": "EndoG3", "cell_subtype": "Other", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191947"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8191947", "tissue": "Primary tumor", "disease": "Serous carcinoma", "sample_type": "tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191947", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191668"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191668", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "HGSC", "tissue": "Ovarian", "description": "This SuperSeries is composed of the SubSeries listed below.", "cell_type": "Serous carcinoma", "sample_type": "Tumor"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191668", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509490"], "tissue": "Omentum", "roi": "011", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509490", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Omentum", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509490", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509184"], "tissue": "Omentum", "roi": "004", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509184", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509184", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191781"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_name": "GSM8191781", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Serous carcinoma", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "assigned_cluster: C4", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_name": "GSE263455", "bioproject_accession": "GSM8191781", "disease": "High grade serous ovarian carcinoma", "tissue": "Ovary", "sample_type": "C4", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192014"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Serous carcinoma", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192014", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "C1", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509285"], "tissue": "Omentum", "roi": "005", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509285", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Omentum", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "Immune", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509285", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509465"], "tissue": "Fallopian Tube", "roi": "009", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509465", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Fallopian Tube", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "Tissue"}, "LLM+CEDAR": {"biosample_accession": "GSM8509465", "sample_name": "009", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191724"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191724", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "phenotype": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191724", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C1", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The chromatin landscape of high-grade serous ovarian cancer metastasis identifies potential regulatory drivers of chemoresistant tumour cells"], "summary": ["Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC) but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determined the single cell chromatin accessibility landscape of omental OC metastasis from treatment na\u00efve and neoadjuvant chemotherapy-treated patients and defined the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells displayed open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX. Chemotherapy drove profound tumour heterogeneity and selection for cells with accessible chromatin enriched for TP53, TP63 and resistance-pathway-activating TF motifs. Nuclear receptors RORa, NR2F6 and HNF4NG were identified as candidate transcriptional drivers of stress-associated chemotherapy resistance whilst closure of binding sites for E2F2 and E2F4 indicated low proliferative capacity of resistant tumour subsets. Delineation of the epigenetic landscape of chemoresistant ovarian cancer therefore reveals core transcriptional regulators of chemoresistance and identifies potential novel therapeutic approaches for improving clinical outcome."], "design": "", "gse": "GSE247982", "gsm": ["GSM7904052"], "tissue": "HGSOC Omentum", "cell type": "mixed", "treatment": "NACT"}, "LLM": {"sample_name": "GSM7904052", "sample_title": "The chromatin landscape of high-grade serous ovarian cancer metastasis identifies potential regulatory drivers of chemoresistant tumour cells", "bioproject_accession": "GSE247982", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "HGSOC Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "mixed", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high-grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "NACT", "description": "Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC) but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determined the single cell chromatin accessibility landscape of omental OC metastasis from treatment na\u00efve and neoadjuvant chemotherapy-treated patients and defined the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells displayed open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX. Chemotherapy drove profound tumour heterogeneity and selection for cells with accessible chromatin enriched for TP53, TP63 and resistance-pathway-activating TF motifs. Nuclear receptors RORa, NR2F6 and HNF4NG were identified as candidate transcriptional drivers of stress-associated chemotherapy resistance whilst closure of binding sites for E2F2 and E2F4 indicated low proliferative capacity of resistant tumour subsets. Delineation of the epigenetic landscape of chemoresistant ovarian cancer therefore reveals core transcriptional regulators of chemoresistance and identifies potential novel therapeutic approaches for improving clinical outcome."}, "LLM+CEDAR": {"biosample_accession": "GSE247982", "sample_name": "GSM7904052", "sample_title": "The chromatin landscape of high-grade serous ovarian cancer metastasis identifies potential regulatory drivers of chemoresistant tumour cells", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "mixed", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "metastasis", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "chemoresistant", "population": "NA", "race": "NA", "sample_type": "tumour cells", "treatment": "neoadjuvant chemotherapy", "description": "Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC) but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determined the single cell chromatin accessibility landscape of omental OC metastasis from treatment na\u00efve and neoadjuvant chemotherapy-treated patients and defined the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells displayed open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX. Chemotherapy drove profound tumour heterogeneity and selection for cells with accessible chromatin enriched for TP53, TP63 and resistance-pathway-activating TF motifs. Nuclear receptors RORa, NR2F6 and HNF4NG were identified as candidate transcriptional drivers of stress-associated chemotherapy resistance whilst closure of binding sites for E2F2 and E2F4 indicated low proliferative capacity of resistant tumour subsets. Delineation of the epigenetic landscape of chemoresistant ovarian cancer therefore reveals core transcriptional regulators of chemoresistance and identifies potential novel therapeutic approaches for improving clinical outcome."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509219"], "tissue": "Ovary", "roi": "010", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509219", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509219", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CD20", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192001"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192001", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "C2", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192001", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192109"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "Serous carcinoma", "biomaterial_provider": "HGSC"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192109", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian neoplasm", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509534"], "tissue": "Fallopian Tube", "roi": "013", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509534", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Human", "tissue": "Fallopian Tube", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509534", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "013", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High Grade Serous Ovarian Cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192099"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192099", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "HGSC", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192099", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185630"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "Assigned cluster: C2", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "sample_type": "tumor"}, "LLM+CEDAR": {"sample_name": "GSM8185630", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192224"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192224", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192224", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191989"], "tissue": "Primary tumor", "histology_cpr": "EndoG3", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191989", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Ovarian cancer", "disease_stage": "EndoG3", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Serous carcinoma", "population": "Not provided", "race": "Not provided", "sample_type": "Primary tumor", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191989", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian Cancer", "disease_stage": "EndoG3", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509256"], "tissue": "Lymph Node", "roi": "001", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509256", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Lymph Node", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Stroma", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509256", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "lymph node", "disease": "high grade serous ovarian cancer", "cell_type": "NA", "sample_type": "Stroma", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192077"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192077", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "HGSC", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192077", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192170"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192170", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "assigned_cluster": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192170", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185596"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "EndoG3", "histology iti": "Endometrioid carcinoma", "assigned cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "Histology cpr: EndoG3, Histology iti: Endometrioid carcinoma, Assigned cluster: C4", "bioproject_accession": "GSE263455", "organism": "", "isolate": "GSM8185596", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "primary tumor", "treatment": ""}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185596", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "EndoG3", "cell_type": "Endometrioid carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509577"], "tissue": "Omentum", "roi": "014", "type": "Stroma", "batch": "2"}, "LLM": {"sample_name": "GSM8509577", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Omentum", "sample_type": "Tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509577", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "014", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "2", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191711"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191711", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "HGSC", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "ovarian", "cell_line": null, "cell_subtype": null, "cell_type": "Serous carcinoma", "culture_collection": null, "dev_stage": null, "disease": "ovarian cancer", "disease_stage": "C1", "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "tissue sample", "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8191711", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "ovary", "disease": "ovarian serous carcinoma", "biosample_accession": "GSE263455", "cell_type": "NA", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192134"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192134", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192134", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191698"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191698", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "phenotype": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tumor tissue"}, "LLM+CEDAR": {"sample_name": ["GSM8191698"], "sample_title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "description": ["This SuperSeries is composed of the SubSeries listed below."], "bioproject_accession": "GSE263455", "disease": "Serous carcinoma", "phenotype": "C2", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "HGSC", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185469"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185469", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "primary tumor", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "not provided", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185469", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "C3", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191876"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191876", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample", "disease_stage": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191876", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185537"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "organism": "", "disease": "ovarian cancer", "tissue": "primary tumor", "bioproject_accession": "GSE263455", "sample_name": "GSM8185537"}, "LLM+CEDAR": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "GSE263455", "tissue": "primary tumor", "disease": "ovarian cancer", "sample_type": "Serous carcinoma", "treatment": "NA", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "C1", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_name": "GSM8185537"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509403"], "tissue": "Omentum", "roi": "002", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509403", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "CD20", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancers", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509403", "sample_name": "002", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "B cell", "cell_type": "Lymphoid structure", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251991"], "tissue": "Peritoneum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251991", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Peritoneum", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "High-grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor or ascites samples", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251991", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Peritoneum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["The chromatin landscape of high-grade serous ovarian cancer metastasis identifies potential regulatory drivers of chemoresistant tumour cells"], "summary": ["Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC) but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determined the single cell chromatin accessibility landscape of omental OC metastasis from treatment na\u00efve and neoadjuvant chemotherapy-treated patients and defined the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells displayed open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX. Chemotherapy drove profound tumour heterogeneity and selection for cells with accessible chromatin enriched for TP53, TP63 and resistance-pathway-activating TF motifs. Nuclear receptors RORa, NR2F6 and HNF4NG were identified as candidate transcriptional drivers of stress-associated chemotherapy resistance whilst closure of binding sites for E2F2 and E2F4 indicated low proliferative capacity of resistant tumour subsets. Delineation of the epigenetic landscape of chemoresistant ovarian cancer therefore reveals core transcriptional regulators of chemoresistance and identifies potential novel therapeutic approaches for improving clinical outcome."], "design": "", "gse": "GSE247982", "gsm": ["GSM7904053"], "tissue": "HGSOC Omentum", "cell type": "mixed", "treatment": "NACT"}, "LLM": {"sample_name": "GSM7904053", "sample_title": "The chromatin landscape of high-grade serous ovarian cancer metastasis identifies potential regulatory drivers of chemoresistant tumour cells", "bioproject_accession": "GSE247982", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "HGSOC Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "mixed", "culture_collection": "", "dev_stage": "", "disease": "Ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "NACT", "description": "Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC) but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determined the single cell chromatin accessibility landscape of omental OC metastasis from treatment na\u00efve and neoadjuvant chemotherapy-treated patients and defined the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells displayed open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX. Chemotherapy drove profound tumour heterogeneity and selection for cells with accessible chromatin enriched for TP53, TP63 and resistance-pathway-activating TF motifs. Nuclear receptors RORa, NR2F6 and HNF4NG were identified as candidate transcriptional drivers of stress-associated chemotherapy resistance whilst closure of binding sites for E2F2 and E2F4 indicated low proliferative capacity of resistant tumour subsets. Delineation of the epigenetic landscape of chemoresistant ovarian cancer therefore reveals core transcriptional regulators of chemoresistance and identifies potential novel therapeutic approaches for improving clinical outcome."}, "LLM+CEDAR": {"biosample_accession": "GSE247982", "sample_name": "GSM7904053", "sample_title": "The chromatin landscape of high-grade serous ovarian cancer metastasis identifies potential regulatory drivers of chemoresistant tumour cells", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "epithelial cells; fibroblast cells; myeloid cells; lymphoid cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "metastasis", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "chemoresistant", "population": "NA", "race": "NA", "sample_type": "tumor cells", "treatment": "neoadjuvant chemotherapy", "description": "Disease recurrence following chemotherapy is a major clinical challenge in ovarian cancer (OC) but little is known regarding how the tumour epigenome regulates transcriptional programs underpinning chemoresistance. We determined the single cell chromatin accessibility landscape of omental OC metastasis from treatment na\u00efve and neoadjuvant chemotherapy-treated patients and defined the chromatin accessibility profiles of epithelial, fibroblast, myeloid and lymphoid cells. Epithelial tumour cells displayed open chromatin regions enriched with motifs for the oncogenic transcription factors MEIS and PBX. Chemotherapy drove profound tumour heterogeneity and selection for cells with accessible chromatin enriched for TP53, TP63 and resistance-pathway-activating TF motifs. Nuclear receptors RORa, NR2F6 and HNF4NG were identified as candidate transcriptional drivers of stress-associated chemotherapy resistance whilst closure of binding sites for E2F2 and E2F4 indicated low proliferative capacity of resistant tumour subsets. Delineation of the epigenetic landscape of chemoresistant ovarian cancer therefore reveals core transcriptional regulators of chemoresistance and identifies potential novel therapeutic approaches for improving clinical outcome."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192110"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "C2", "treatment": "", "sample_name": "GSM8192110"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192110", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C2", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509223"], "tissue": "Ovary", "roi": "011", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509223", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Stroma", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509223", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "011", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "1", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509535"], "tissue": "Fallopian Tube", "roi": "014", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509535", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Fallopian Tube", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSM8509535", "sample_name": "014", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185546"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "HGSC", "description": "Serous carcinoma", "sample_name": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185546", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "primary tumor", "disease": "ovarian cancer", "sample_type": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191983"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "disease": "Serous carcinoma", "sample_type": "HGSC", "culture_collection": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8191983", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Primary tumor", "disease": "Serous carcinoma", "sample_type": "HGSC", "biomaterial_provider": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509180"], "tissue": "Omentum", "roi": "003", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509180", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "High grade serous ovarian cancers patient", "age": "not collected", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "female", "tissue": "Omentum", "cell_line": "not applicable", "cell_subtype": "not applicable", "cell_type": "Stroma", "culture_collection": "not applicable", "dev_stage": "not applicable", "disease": "High grade serous ovarian cancers", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509180", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191729"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191729", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "Ovarian", "description": "This SuperSeries is composed of the SubSeries listed below. Histology CPR is HGSC. Histology ITI is Serous carcinoma. Assigned cluster is C2."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191729", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509282"], "tissue": "Omentum", "roi": "004", "type": "Tumor", "batch": "1"}, "LLM": {"sample_name": "GSM8509282", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Omentum", "sample_type": "Tumor", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509282", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "004", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Tumor Cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509267"], "tissue": "Lymph Node", "roi": "005", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509267", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Lymph Node", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Stroma", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509267", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "lymph node", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509513"], "tissue": "Ovary", "roi": "018", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509513", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509513", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "018", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509225"], "tissue": "Ovary", "roi": "012", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509225", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "HGSOC patient", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Ovary", "cell_line": "Not applicable", "cell_subtype": "Not applicable", "cell_type": "Stroma", "culture_collection": "Not applicable", "dev_stage": "Not applicable", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Cancerous", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509225", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "012", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185456"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "Serous carcinoma", "phenotype": "HGSC", "population": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185456", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Serous carcinoma", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251962"], "tissue": "Peritoneum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251962", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "isolate": "HGSC patient", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Peritoneum", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "high-grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor or ascites samples", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251962", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Peritoneum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor or ascites samples", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185578"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": null, "isolate": null, "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "primary tumor", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": null, "treatment": null, "description": null}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185578", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian neoplasm", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509548"], "tissue": "Ovary", "roi": "007", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509548", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSM8509548", "sample_name": "007", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185380"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185380", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "primary tumor", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "tissue sample", "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185380", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian serous adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185437"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "Serous carcinoma", "sample_type": "tumor tissue", "biomaterial_provider": "Not Provided", "isolate": "Not Provided", "age": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "treatment": "Not Provided", "sample_name": "GSM8185437"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185437", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian neoplasm", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191649"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8191649", "bioproject_accession": "GSE263455", "organism": "Human", "tissue": "Serous carcinoma", "disease": "HGSC", "cell_type": "Cancer Cell", "phenotype": "Assigned Cluster C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191649", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "ovary", "cell_type": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "age": "NA", "organism": "Homo sapiens", "isolate": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304109"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR3", "cell type": "epithelial cells", "treatment": "0.4 nM paclitaxel for 24 hours"}, "LLM": {"sample_name": "GSM8304109", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR3", "cell_subtype": "", "cell_type": "epithelial cells", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "cell culture", "treatment": "0.4 nM paclitaxel for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8304109", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "OVCAR3", "cell_subtype": "NA", "cell_type": "epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "0.4 nM paclitaxel for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509537"], "tissue": "Ovary", "roi": "001", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509537", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "female", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509537", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "tissue": "ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "disease": "high grade serous ovarian cancer", "cell_type": "Immune", "bioproject_accession": "NA", "isolate": "001", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251984"], "tissue": "Omentum", "treatment": "NACT"}, "LLM": {"sample_name": "GSM8251984", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "tissue": "Omentum", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251984", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients.", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NACT"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509512"], "tissue": "Ovary", "roi": "017", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509512", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509512", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185368"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "JGOG3025-TR2", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "GSM8185368", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "diseased", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8185368", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509441"], "tissue": "Fallopian Tube", "roi": "015", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509441", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Fallopian Tube", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509441", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191798"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8191798", "tissue": "HGSC", "disease": "Serous carcinoma", "phenotype": "C2"}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8191798", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "ovary", "cell_type": "NA", "culture_collection": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "isolate": "NA", "organism": "Homo sapiens", "biosample_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185565"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185565", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185565", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "HGSC", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192113"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192113", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "C3", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192113", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509316"], "tissue": "Ovary", "roi": "003", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509316", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "CD20", "culture_collection": "", "dev_stage": "", "disease": "High grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509316", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer", "organism": "NA", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CD20", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "1", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192181"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "HGSC", "disease_stage": "Serous carcinoma", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192181", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "C2", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251953"], "tissue": "Ovary", "treatment": "NACT"}, "LLM": {"sample_name": "GSM8251953", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High-grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor or ascites sample", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251953", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "T-cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor or ascites samples", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185444"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "primary tumor", "disease": "ovarian cancer", "cell_type": "Serous carcinoma"}, "LLM+CEDAR": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "GSE263455", "sample_name": "GSM8185444", "disease": "ovarian cancer", "tissue": "ovarian primary tumor", "phenotype": "High-Grade Serous Carcinoma", "sample_type": "Serous carcinoma", "population": "C2", "biomaterial_provider": "NA", "sex": "NA", "age": "NA", "organism": "NA", "isolate": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "race": "NA", "treatment": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251965"], "tissue": "Omentum", "treatment": "NACT"}, "LLM": {"title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "summary": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients.", "bioproject_accession": "GSE266577", "gsm": "GSM8251965", "tissue": "Omentum", "treatment": "NACT", "sample_name": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "description": ""}, "LLM+CEDAR": {"biosample_accession": "GSM8251965", "sample_name": "NA", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor or ascites samples", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509306"], "tissue": "Omentum", "roi": "008", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509306", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509306", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "008", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CD20", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185366"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "biomaterial_provider": "Not Available", "disease_stage": "Serous carcinoma"}, "LLM+CEDAR": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8185366", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "biosample_accession": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509329"], "tissue": "Ovary", "roi": "008", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509329", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "CD20", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509329", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "008", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "B cell", "cell_type": "lymphoid", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192202"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8192202", "organism": "Not provided", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "cell_type": "Cancer cell", "disease": "Serous carcinoma", "disease_stage": "Not provided", "sample_type": "Tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below.", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "cell_line": "Not provided", "cell_subtype": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "treatment": "Not provided"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192202", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509497"], "tissue": "Ovary", "roi": "002", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509497", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "Immune", "culture_collection": "", "dev_stage": "", "disease": "High grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "002", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509280"], "tissue": "Omentum", "roi": "004", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509280", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509280", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "004", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185599"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "cell_type": "Serous carcinoma", "sample_type": "tissue sample", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8185599", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509449"], "tissue": "Ovary", "roi": "006", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509449", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Immune", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancers", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509449", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "006", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185514"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185514", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185514", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191981"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "GSM8191981", "tissue": "Primary tumor", "disease": "HGSC", "cell_type": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191981", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509459"], "tissue": "Fallopian Tube", "roi": "003", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509459", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Fallopian Tube", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Immune", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "high grade serous ovarian cancers", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Cancer", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Tissue", "treatment": "Not Provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509459", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191908"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191908", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Unknown", "age": "Unknown", "biomaterial_provider": "Unknown", "collection_date": "Unknown", "geo_loc_name": "Unknown", "sex": "Unknown", "tissue": "Ovarian", "cell_line": "Unknown", "cell_subtype": "Unknown", "cell_type": "Cancer", "culture_collection": "Unknown", "dev_stage": "Unknown", "disease": "Serous carcinoma", "disease_stage": "Unknown", "ethnicity": "Unknown", "health_state": "HGSC", "karyotype": "Unknown", "phenotype": "C2", "population": "Unknown", "race": "Unknown", "sample_type": "Tissue sample", "treatment": "Unknown", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8191908", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "ovary", "sample_type": "HGSC", "cell_type": "Serous carcinoma", "phenotype": "C2", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192159"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192159", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Ovarian Cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192159", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509289"], "tissue": "Omentum", "roi": "007", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509289", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Stroma", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509289", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "007", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Stroma", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185350"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "-"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_name": "GSM8185350", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185350", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509271"], "tissue": "Omentum", "roi": "001", "type": "Stroma", "batch": "1"}, "LLM": {"sample_name": "GSM8509271", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not Available", "age": "Not Available", "biomaterial_provider": "Not Available", "collection_date": "Not Available", "geo_loc_name": "Not Available", "sex": "Not Available", "tissue": "Omentum", "cell_line": "Not Available", "cell_subtype": "Stroma", "cell_type": "Not Available", "culture_collection": "Not Available", "dev_stage": "Not Available", "disease": "high grade serous ovarian cancer", "disease_stage": "Not Available", "ethnicity": "Not Available", "health_state": "Not Available", "karyotype": "Not Available", "phenotype": "Not Available", "population": "Not Available", "race": "Not Available", "sample_type": "Tissue", "treatment": "Not Available", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509271", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191889"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191889", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Tumor", "health_state": "Cancer", "cell_type": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8191889", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "ovarian serous cystadenocarcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185574"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "Histology CPR: HGSC, Histology ITI: Serous carcinoma, Assigned cluster: C1", "sample_name": "GSM8185574"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185574", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "HGSC", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509502"], "tissue": "Ovary", "roi": "007", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509502", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509502", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509236"], "tissue": "Ovary", "roi": "002", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509236", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509236", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "002", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192098"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192098", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "Serous carcinoma", "phenotype": "HGSC", "sample_type": "Primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "cluster": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192098", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192008"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "JGOG3025-TR2", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "phenotype": "HGSC", "disease": "Serous carcinoma", "sample_type": "tissue sample", "biomaterial_provider": "GSM8192008", "assigned_cluster": "C1"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192008", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191831"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191831", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High-grade serous carcinoma (HGSC)", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191831", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509411"], "tissue": "Omentum", "roi": "007", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509411", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "CD20", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509411", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "organism": "NA", "isolate": "007", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "B cell", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA"}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304129"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR4", "cell type": "epithelial cells", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours"}, "LLM": {"sample_name": "GSM8304129", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "female", "tissue": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR4", "cell_type": "epithelial cells", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "phenotype": "not provided", "population": "not provided", "sample_type": "cell culture", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "GSE268985", "sample_name": "GSM8304129", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "OVCAR4", "cell_subtype": "NA", "cell_type": "epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "cell line", "treatment": "0.4 nM paclitaxel and 500 nM RBN-2397 for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191782"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "sample_name": "GSM8191782", "organism": "Human", "disease": "HGSC", "disease_stage": "Serous carcinoma", "biomaterial_provider": "C4"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191782", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185627"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Other", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "HGSC", "sample_type": "tumor sample", "isolate": "GSM8185627", "biomaterial_provider": "C2"}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "age": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "phenotype": "NA", "sample_type": "NA", "description": "This SuperSeries is composed of the SubSeries listed below.", "biomaterial_provider": "NA", "culture_collection": "NA", "dev_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "biosample_accession": "GSM8185627", "bioproject_accession": "NA", "isolate": "NA"}}
{"BioSample": {"title": ["Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)"], "summary": ["We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype.", "ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients.", ""], "design": "", "gse": "GSE224392", "gsm": ["GSM7021606"], "cell type": "HGSOC", "tissue": "Omentum"}, "LLM": {"sample_name": "GSM7021606", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "GSE224392", "organism": "Homo sapiens", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Omentum", "cell_line": "", "cell_subtype": "", "cell_type": "HGSOC", "culture_collection": "", "dev_stage": "", "disease": "high-grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor-infiltrating immune cells", "treatment": "neo-adjuvant chemotherapy (NACT)", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype."}, "LLM+CEDAR": {"biosample_accession": "GSE224392", "sample_name": "GSM7021606", "sample_title": "Immunotherapies that repolarize macrophages and regulatory T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer (Human)", "bioproject_accession": "NA", "organism": "Human", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSOC", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor-infiltrating immune cells", "treatment": "chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO", "description": "We conducted single-cell RNA sequencing (scRNAseq) of tumor-infiltrating immune cells in high-grade serous ovarian cancer (HGSOC) omental biopsies to identify potential targets that could enhance response to neo-adjuvant chemotherapy (NACT). Analysis of 64,097 cells identified NACT-induced overexpression of stabilin-1 (clever-1) on macrophages and FOXP3 in Tregs and these were validated at the protein level. STAB1 inhibition in vitro induced anti-tumor macrophages. FOXP3 anti-sense oligonucleotide (FOXP3-ASO), repolarised Tregs to an effector T cell phenotype. ScRNAseq on 69,781 cells from an HGSOC syngeneic mouse model recapitulated the patients\u2019 data. Combining chemotherapy with anti-stabilin1 antibody and/or Foxp3-ASO significantly increased survival of mice with established peritoneal disease in two HGSOC syngeneic models and progression-free survival in a third model. Long-term survivors (300 days+) were resistant to tumor rechallenge. Anti-stabilin1 antibody enriched the tumors with CXCL9+ macrophages and Foxp3-ASO increased TBET cell infiltration. Our results suggest targeting these molecules may improve chemotherapy response in patients."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251966"], "tissue": "Omentum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251966", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "tissue": "Omentum", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients.", "treatment": "Chemo-naive"}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": ["GSM8251966"], "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "T-cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191875"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191875", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191875", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C3", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509406"], "tissue": "Omentum", "roi": "003", "type": "Other", "batch": "2"}, "LLM": {"sample_name": "GSM8509406", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "003", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Other", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509406", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Other", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192131"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192131", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Human", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Ovarian Cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192131", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian Serous Cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509580"], "tissue": "Ovary", "roi": "002", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509580", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "002", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509580", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509398"], "tissue": "Omentum", "roi": "013", "type": "Stroma", "batch": "2"}, "LLM": {"sample_name": "GSM8509398", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "not provided", "tissue": "Omentum", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "Stroma", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "not provided", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "Tumor tissue", "treatment": "not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSM8509398", "sample_name": "013", "sample_title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Stroma", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."]}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191892"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191892", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "cell_type": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "tissue sample", "disease_stage": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8191892", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "cell_type": "Serous carcinoma", "sample_type": "C2", "tissue": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192088"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "N/A", "isolate": "GSM8192088", "age": "N/A", "biomaterial_provider": "N/A", "collection_date": "N/A", "geo_loc_name": "N/A", "sex": "N/A", "tissue": "Primary tumor", "cell_line": "N/A", "cell_subtype": "N/A", "cell_type": "N/A", "culture_collection": "N/A", "dev_stage": "N/A", "disease": "HGSC", "disease_stage": "N/A", "ethnicity": "N/A", "health_state": "N/A", "karyotype": "N/A", "phenotype": "C2", "population": "N/A", "race": "N/A", "sample_type": "Serous carcinoma", "treatment": "N/A", "sample_name": "N/A"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192088", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology."], "summary": ["PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."], "design": "", "gse": "GSE268985", "gsm": ["GSM8304122"], "tissue": "high-grade serous ovarian adenocarcinoma", "cell line": "OVCAR4", "cell type": "epithelial cells", "treatment": "0.4 nM paclitaxel for 24 hours"}, "LLM": {"sample_name": "GSM8304122", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "GSE268985", "organism": "Homo sapiens", "isolate": "high-grade serous ovarian adenocarcinoma", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "high-grade serous ovarian adenocarcinoma", "cell_line": "OVCAR4", "cell_type": "epithelial cells", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "cancerous", "phenotype": "Not provided", "population": "Not provided", "sample_type": "cell culture", "treatment": "0.4 nM paclitaxel for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}, "LLM+CEDAR": {"biosample_accession": "GSE268985", "sample_name": "GSM8304122", "sample_title": "Effect of RBN-2397, paclitaxel and their combination on ovarian cancer cell biology.", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "OVCAR4", "cell_subtype": "epithelial cells", "cell_type": "epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "high-grade serous ovarian adenocarcinoma", "treatment": "0.4 nM paclitaxel for 24 hours", "description": "PARP7 (TiPARP), a mono (ADP-ribosyl) transferase (MART) was found to target \u03b1-tubulin proteins in ovarian cancer cells, enhancing their growth and migration. RBN-2397 is a potent inhibitor that selectively acts on PARP7. Here, we show that RBN-2397 treatment leads to the stabilization of microtubules in ovarian cancer cells, namely \u03b1-tubulin, mimicking what was previously observed with PARP7 knockdown. When treated with RBN-2397, we observe a decrease in growth and migration of ovarian cancer cells and, interestingly, the effect is intensified upon adding the microtubule stabilizing chemotherapeutic agent, paclitaxel. Mutating the site of \u03b1-tubulin MARylation by PARP7 similarly results in \u03b1-tubulin stabilization and decreased cell migration in the presence of paclitaxel when the tubulin network is further stabilized. In sum, we demonstrate that PARP7 inhibition decreases \u03b1-tubulin MARylation resulting in its stabilization, and ultimately leading to decreased ovarian cancer cell proliferation and migration. Finally, we show that combining PARP7 inhibitor and paclitaxel results in a more robust inhibition of aggressive ovarian cancer phenotypes. Collectively, this study highlights the potential of targeting PARP7 in combination with established chemotherapeutic agents to enhance treatment efficacy for ovarian cancer."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509330"], "tissue": "Ovary", "roi": "008", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509330", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "Immune", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509330", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "008", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509202"], "tissue": "Ovary", "roi": "003", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509202", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "003", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancers", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509202", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191911"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Serous carcinoma", "sample_type": "HGSC", "sample_name": "GSM8191911", "cell_type": "C3"}, "LLM+CEDAR": {"sample_name": "GSM8191911", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "High-grade serous ovarian carcinoma", "tissue": "Ovary", "sample_type": "C3", "biomaterial_provider": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "biosample_accession": "GSE263455", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA"}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251975"], "tissue": "Omentum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251975", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High-grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSM8251975", "sample_name": "NA", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor or ascites sample", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509547"], "tissue": "Ovary", "roi": "006", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509547", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "female", "tissue": "Ovary", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Immune", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Cancer", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "tissue sample", "treatment": "Not Provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509547", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "006", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509554"], "tissue": "Ovary", "roi": "013", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509554", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Ovary", "cell_line": "Not applicable", "cell_subtype": "Not applicable", "cell_type": "Cancer cell", "culture_collection": "Not applicable", "dev_stage": "Not applicable", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Diseased", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509554", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191742"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191742", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Serous carcinoma", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "C3", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191742", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous adenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191952"], "tissue": "Primary tumor", "histology_cpr": "EndoG3", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "disease": "Endometrioid carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191952", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Primary tumor", "disease": "Endometrioid carcinoma", "sample_type": "C2", "biomaterial_provider": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "EndoG3", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185356"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "biomaterial_provider": "NA", "tissue": "primary tumor", "disease": "ovarian cancer", "sample_type": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "GSM8185356", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "C4", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192021"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C4"}, "LLM": {"sample_name": "GSM8192021", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC, Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192021", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251955"], "tissue": "Omentum", "treatment": "NACT"}, "LLM": {"sample_name": "GSM8251955", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "tissue": "Omentum", "treatment": "NACT", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSM8251955", "sample_name": "NA", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "T-cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor or ascites samples", "treatment": "Neoadjuvant chemotherapy", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509250"], "tissue": "Ovary", "roi": "009", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509250", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "009", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Ovary", "cell_line": "", "cell_subtype": "", "cell_type": "CD20", "culture_collection": "", "dev_stage": "", "disease": "high grade serous ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tumor", "treatment": "", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509250", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "009", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CD20", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185391"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185391", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185391", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "C2", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185480"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "-"}, "LLM": {"sample_name": "GSM8185480", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "description": "This SuperSeries is composed of the SubSeries listed below. Histology cpr: HGSC, Histology iti: Serous carcinoma, Assigned cluster: -"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185480", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509583"], "tissue": "Ovary", "roi": "005", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509583", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509583", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191685"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8191685", "tissue": "HGSC", "disease": "Serous carcinoma", "sample_type": "C3"}, "LLM+CEDAR": {"bioproject_accession": "GSE263455", "sample_name": "GSM8191685", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192211"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192211", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192211", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor tissue", "treatment": "NA", "description": "High-grade serous ovarian cancer"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509446"], "tissue": "Ovary", "roi": "004", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509446", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8509446", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "004", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "2", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192130"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192130", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tumor sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192130", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192139"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "tissue": "Primary tumor", "disease": "HGSC", "phenotype": "Serous carcinoma", "sample_name": "GSM8192139"}, "LLM+CEDAR": {"sample_name": "GSM8192139", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "Primary tumor", "disease": "Serous carcinoma", "biomaterial_provider": "HGSC", "sample_type": "C3", "bioproject_accession": "GSE263455", "biosample_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509501"], "tissue": "Ovary", "roi": "006", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509501", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Female", "tissue": "Ovary", "cell_line": "Not applicable", "cell_subtype": "Not applicable", "cell_type": "Not applicable", "culture_collection": "Not applicable", "dev_stage": "Not applicable", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509501", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "006", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191894"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191894", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease_stage": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191894", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "C3", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous cystadenocarcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191857"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "sample_type": "assigned_cluster: C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191857", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "HGSC", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191736"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8191736", "disease": "HGSC", "tissue": "Serous carcinoma", "sample_type": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8191736", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below. High-grade serous carcinoma (HGSC), Cluster C2"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185488"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C4"}, "LLM": {"sample_name": "GSM8185488", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185488", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509412"], "tissue": "Omentum", "roi": "007", "type": "Other", "batch": "2"}, "LLM": {"sample_name": "GSM8509412", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Other", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509412", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Other", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191832"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "sample_name": "GSM8191832", "disease": "HGSC", "tissue": "Serous carcinoma", "population": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191832", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192052"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "gse": "GSE263455", "gsm": "GSM8192052", "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Endometrioid carcinoma", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192052", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "primary tumor", "disease": "Endometrioid carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251987"], "tissue": "Peritoneum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251987", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "tissue": "Peritoneum", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251987", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Peritoneum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "T-cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191755"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191755", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Serous carcinoma", "disease": "Ovarian cancer", "disease_stage": "HGSC", "sample_type": "Tumor tissue"}, "LLM+CEDAR": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "GSE263455", "sample_name": "GSM8191755", "tissue": "ovary", "disease": "high grade serous ovarian carcinoma", "sample_type": "NA", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509529"], "tissue": "Fallopian Tube", "roi": "009", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509529", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Fallopian Tube", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "NA", "sample_name": "GSM8509529", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185487"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "summary": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "Serous carcinoma", "sample_type": "tissue sample", "description": "A study of HGSC ovarian cancer, assigned to cluster C1. Sample GSM8185487."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185487", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "Ovarian Neoplasm", "tissue": "Ovarian Tissue", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192190"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192190", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "HGSC", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Primary tumor", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Serous carcinoma", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "Ovarian cancer", "disease_stage": "C2", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Tumor tissue", "treatment": "Not Provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192190", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Serous carcinoma", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192143"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Primary tumor", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Tissue sample", "health_state": "HGSC", "cell_type": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192143", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509477"], "tissue": "Omentum", "roi": "003", "type": "CD20", "batch": "2"}, "LLM": {"sample_name": "GSM8509477", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Human", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509477", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "003", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CD20", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "2", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191766"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191766", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "tissue": "HGSC", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "Not Provided", "cell_type": "Cancer Cell"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191766", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509332"], "tissue": "Ovary", "roi": "009", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509332", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "sample_type": "tissue sample", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509332", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "NA", "isolate": "009", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "CD20", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192145"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_type": "Primary tumor", "tissue": "Primary tumor", "disease": "Serous carcinoma", "bioproject_accession": "GSE263455", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192145", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Epithelial cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192096"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192096", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192096", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C2", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509239"], "tissue": "Ovary", "roi": "003", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509239", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "bioproject_accession": "GSE276935", "age": "Not Provided", "biomaterial_provider": "Unknown", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Female", "tissue": "Ovary", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Immune", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "High grade serous ovarian cancers", "disease_stage": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Tissue Sample", "treatment": "Not Provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509239", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Ovary", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185358"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C1"}, "LLM": {"sample_name": "GSM8185358", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185358", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509308"], "tissue": "Omentum", "roi": "009", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509308", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509308", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "B cells", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191732"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "cell_line": "GSM8191732", "tissue": "HGSC", "disease": "Serous carcinoma", "phenotype": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191732", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "HGSC", "cell_subtype": "Serous carcinoma", "cell_type": "C2", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509377"], "tissue": "Fallopian Tube", "roi": "007", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509377", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not Provided", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Fallopian Tube", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "high grade serous ovarian cancer", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Tissue sample", "treatment": "Not Provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509377", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "007", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Fallopian Tube", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192045"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8192045", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192045", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "Assigned Cluster: C3", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191998"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191998", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Not provided", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191998", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C1", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191835"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191835", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Ovarian Cancer Patient", "age": "not provided", "biomaterial_provider": "not provided", "collection_date": "not provided", "geo_loc_name": "not provided", "sex": "female", "tissue": "ovarian", "cell_line": "not provided", "cell_subtype": "not provided", "cell_type": "not provided", "culture_collection": "not provided", "dev_stage": "not provided", "disease": "Serous carcinoma", "disease_stage": "HGSC", "ethnicity": "not provided", "health_state": "not provided", "karyotype": "not provided", "phenotype": "not provided", "population": "not provided", "race": "not provided", "sample_type": "tissue sample", "treatment": "not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191835", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192062"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192062", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "HGSC", "disease_stage": "C2", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192062", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509220"], "tissue": "Ovary", "roi": "010", "type": "Immune", "batch": "1"}, "LLM": {"sample_name": "GSM8509220", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "Ovary", "cell_line": null, "cell_subtype": null, "cell_type": "Immune", "culture_collection": null, "dev_stage": null, "disease": "high grade serous ovarian cancer", "disease_stage": "High grade", "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": "tissue sample", "treatment": null, "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509220", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509507"], "tissue": "Ovary", "roi": "012", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509507", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovary", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509507", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Full ROI", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192040"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192040", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "HGSC", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185500"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "primary tumor", "bioproject_accession": "GSE263455", "sample_name": "GSM8185500", "phenotype": "HGSC", "cell_type": "Serous carcinoma", "population": "C2"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185500", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "tissue": "UBERON:0002367", "disease": "DOID:2394", "description": "This SuperSeries is composed of the SubSeries listed below.", "sample_type": "primary tumor", "biomaterial_provider": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "CL:0002327", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "organism": "NA", "age": "NA", "isolate": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185465"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185465", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "age": null, "biomaterial_provider": null, "collection_date": null, "geo_loc_name": null, "sex": null, "tissue": "primary tumor", "cell_line": null, "cell_subtype": null, "cell_type": null, "culture_collection": null, "dev_stage": null, "disease": "ovarian cancer", "disease_stage": null, "ethnicity": null, "health_state": null, "karyotype": null, "phenotype": null, "population": null, "race": null, "sample_type": null, "treatment": null, "description": "This SuperSeries is composed of the SubSeries listed below.", "isolate": null}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185465", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "HGSC", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer"], "summary": ["To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."], "design": "", "gse": "GSE266577", "gsm": ["GSM8251948"], "tissue": "Peritoneum", "treatment": "Chemo-naive"}, "LLM": {"sample_name": "GSM8251948", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "GSE266577", "organism": "Homo sapiens", "tissue": "Peritoneum", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}, "LLM+CEDAR": {"biosample_accession": "GSE266577", "sample_name": "GSM8251948", "sample_title": "Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Peritoneum", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High-grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "Chemo-naive", "description": "To characterize the spatial tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSC) at the single cell level, we performed single-cell RNA sequencing (scRNA-seq) on 48 tumor or ascites samples from 29 HGSC patients. This data set includes paired scRNA-seq data from chemo-naive and post-neoadjuvant chemotherapy (IDS) samples of 22 HGSC patients."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191861"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "phenotype": "HGSC", "cell_type": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191861", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "C3", "cell_type": "Serous carcinoma", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185524"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_name": "GSM8185524", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "primary tumor", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Not provided", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185524", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192179"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "sample_type": "Tissue sample", "tissue": "Primary tumor", "bioproject_accession": "GSE263455", "disease": "Serous carcinoma", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192179", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Serous carcinoma", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185603"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C2"}, "LLM": {"sample_name": "GSM8185603", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSE263455", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "disease": "ovarian cancer", "tissue": "primary tumor", "sample_type": "Serous carcinoma", "phenotype": "HGSC", "treatment": "NA", "biomaterial_provider": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "population": "NA", "race": "NA", "bioproject_accession": "NA", "biosample_accession": "GSM8185603"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191828"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8191828", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "isolate": "Not provided", "age": "Not provided", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Ovarian", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "Cancer cell", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "Serous carcinoma", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tissue sample", "treatment": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"sample_name": "GSM8191828", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "High grade serous ovarian carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509560"], "tissue": "Ovary", "roi": "018", "type": "Immune", "batch": "2"}, "LLM": {"sample_name": "GSM8509560", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "tissue": "Ovary", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "sample_type": "tissue sample"}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509560", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "NA", "isolate": "018", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "Immune", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Tissue", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191692"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191692", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "tissue": "Ovarian", "disease": "Serous carcinoma", "sample_type": "Tumor", "description": "This SuperSeries is composed of the SubSeries listed below.", "phenotype": "HGSC", "population": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191692", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Ovary", "cell_line": "NA", "cell_subtype": "Serous carcinoma", "cell_type": "HGSC", "culture_collection": "NA", "dev_stage": "NA", "disease": "Ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C3", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192006"], "tissue": "Primary tumor", "histology_cpr": "EndoG3", "histology_iti": "Serous carcinoma", "assigned_cluster": "C2"}, "LLM": {"sample_name": "GSM8192006", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "EndoG3", "disease_stage": "Serous carcinoma", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Primary tumor", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below.", "assigned_cluster": "C2"}, "LLM+CEDAR": {"sample_name": "GSM8192006", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "EndoG3", "culture_collection": "NA", "dev_stage": "NA", "disease": "Serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "C2", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below.", "biosample_accession": "GSE263455", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191867"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8191867", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "HGSC", "cell_line": "", "cell_subtype": "", "cell_type": "Serous carcinoma", "culture_collection": "", "dev_stage": "", "disease": "Ovarian cancer", "disease_stage": "", "ethnicity": "", "health_state": "", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "Cancer tissue sample", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191867", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian serous carcinoma", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191688"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "sample_type": "tissue sample", "tissue": "ovary", "phenotype": "HGSC"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191688", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below"}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509417"], "tissue": "Omentum", "roi": "010", "type": "Full ROI", "batch": "2"}, "LLM": {"sample_name": "GSM8509417", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "GSE276935", "organism": "Homo sapiens", "isolate": "Not Provided", "age": "Not Provided", "biomaterial_provider": "Not Provided", "collection_date": "Not Provided", "geo_loc_name": "Not Provided", "sex": "Not Provided", "tissue": "Omentum", "cell_line": "Not Provided", "cell_subtype": "Not Provided", "cell_type": "Not Provided", "culture_collection": "Not Provided", "dev_stage": "Not Provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not Provided", "ethnicity": "Not Provided", "health_state": "Not Provided", "karyotype": "Not Provided", "phenotype": "Not Provided", "population": "Not Provided", "race": "Not Provided", "sample_type": "Tissue sample", "treatment": "Not Provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": ["GSM8509417"], "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation.", "tissue": "Omentum", "disease": "high grade serous ovarian cancer", "sample_type": "Full ROI", "biomaterial_provider": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "sex": "NA", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "treatment": "NA", "bioproject_accession": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8191823"], "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C3"}, "LLM": {"sample_name": "GSM8191823", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "Serous carcinoma", "biomaterial_provider": "Not provided", "description": "This SuperSeries is composed of the SubSeries listed below.", "tissue": "HGSC", "sample_type": "Tumor tissue"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8191823", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovary", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tissue", "treatment": "NA", "description": "NA"}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8192067"], "tissue": "Primary tumor", "histology_cpr": "HGSC", "histology_iti": "Serous carcinoma", "assigned_cluster": "C1"}, "LLM": {"sample_name": "GSM8192067", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "GSE263455", "organism": "", "isolate": "", "age": "", "biomaterial_provider": "", "collection_date": "", "geo_loc_name": "", "sex": "", "tissue": "Primary tumor", "cell_line": "", "cell_subtype": "", "cell_type": "", "culture_collection": "", "dev_stage": "", "disease": "Serous carcinoma", "disease_stage": "", "ethnicity": "", "health_state": "HGSC", "karyotype": "", "phenotype": "", "population": "", "race": "", "sample_type": "", "treatment": "", "description": "This SuperSeries is composed of the SubSeries listed below."}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8192067", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "ovarian tissue", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "cancer cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "Primary tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185606"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Serous carcinoma", "assigned cluster": "C3"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "Serous carcinoma", "bioproject_accession": "GSE263455", "organism": "Homo sapiens", "disease": "ovarian cancer", "tissue": "primary tumor", "isolate": "GSM8185606", "phenotype": "HGSC", "sample_type": "C3"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185606", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
{"BioSample": {"title": ["The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions"], "summary": ["Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."], "design": "", "gse": "GSE276935", "gsm": ["GSM8509192"], "tissue": "Omentum", "roi": "008", "type": "CD20", "batch": "1"}, "LLM": {"sample_name": "GSM8509192", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "organism": "Homo sapiens", "biomaterial_provider": "Not provided", "collection_date": "Not provided", "geo_loc_name": "Not provided", "sex": "Not provided", "tissue": "Omentum", "cell_line": "Not provided", "cell_subtype": "Not provided", "cell_type": "CD20", "culture_collection": "Not provided", "dev_stage": "Not provided", "disease": "High grade serous ovarian cancer", "disease_stage": "Not provided", "ethnicity": "Not provided", "health_state": "Not provided", "karyotype": "Not provided", "phenotype": "Not provided", "population": "Not provided", "race": "Not provided", "sample_type": "Tumor tissue", "treatment": "Not provided", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}, "LLM+CEDAR": {"biosample_accession": "GSE276935", "sample_name": "GSM8509192", "sample_title": "The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions", "bioproject_accession": "NA", "organism": "Homo sapiens", "isolate": "008", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "Omentum", "cell_line": "NA", "cell_subtype": "CD20", "cell_type": "B cell", "culture_collection": "NA", "dev_stage": "NA", "disease": "high grade serous ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "NA", "population": "NA", "race": "NA", "sample_type": "tumor", "treatment": "NA", "description": "Most high grade serous ovarian cancers (HGSOC) originate in the fallopian tube but spread to the ovary and peritoneal cavity, highlighting the need to understand antitumor immunity across HGSOC sites. Using spatial analyses, we discover that tertiary lymphoid structures (TLS) within ovarian tumors are less developed compared with TLS in fallopian tube or omental tumors. We reveal transcriptional differences across a spectrum of lymphoid structures, demonstrating that immune cell activity increases when residing in more developed TLS and produce a prognostic, spatially derived TLS signature from HGSOC tumors. We interrogate TLS-adjacent stroma and assess how normal mesenchymal stem cells MSCs (nMSCs) may support B cell function and TLS, contrary to cancer-educated MSCs (CA-MSCs) which negate the prognostic benefit of our TLS signature, suggesting that pro-tumorigenic stroma could limit TLS formation."}}
{"BioSample": {"title": ["Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort"], "summary": ["This SuperSeries is composed of the SubSeries listed below."], "design": "", "gse": "GSE263455", "gsm": ["GSM8185461"], "disease state": "ovarian cancer", "tissue": "primary tumor", "histology cpr": "HGSC", "histology iti": "Endometrioid carcinoma", "assigned cluster": "C4"}, "LLM": {"sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "description": "This SuperSeries is composed of the SubSeries listed below.", "bioproject_accession": "GSE263455", "disease": "ovarian cancer", "tissue": "primary tumor", "phenotype": "HGSC", "cell_type": "Endometrioid carcinoma", "isolate": "C4"}, "LLM+CEDAR": {"biosample_accession": "GSE263455", "sample_name": "GSM8185461", "sample_title": "Multi-omics data analysis for the JGOG3025-TR2 ovarian cancer cohort", "bioproject_accession": "NA", "organism": "NA", "isolate": "NA", "age": "NA", "biomaterial_provider": "NA", "sex": "NA", "tissue": "primary tumor", "cell_line": "NA", "cell_subtype": "NA", "cell_type": "NA", "culture_collection": "NA", "dev_stage": "NA", "disease": "ovarian cancer", "disease_stage": "NA", "ethnicity": "NA", "health_state": "NA", "karyotype": "NA", "phenotype": "C4", "population": "NA", "race": "NA", "sample_type": "NA", "treatment": "NA", "description": "This SuperSeries is composed of the SubSeries listed below."}}
